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Abstract: Herein, we report a new method for the synthesis of bi-
heteroaryls, based on the Umpolung of indoles with benziodoxol(on)e 
hypervalent iodine reagents (IndoleBX). The oxidative coupling of 
IndoleBX with an equimolar amount of electron-rich benzenes, indoles, 
pyrroles and thiophenes proceeded under mild transition-metal free 
conditions. Functionalized non-symmetrical bi-indolyl heterocycles 
were accessed efficiently. Introduction of a new type of C2-substituted 
indole benziodoxole reagents further allowed extending the scope of 
the reaction to NH unprotected and C3-alkylated indoles. The 
obtained bi-heterocycles are important building blocks in synthetic 
and medicinal chemistry, and could be easily transformed into more 
complex heterocyclic systems. 
Bi- and oligo- (hetero)aryl indoles are important building 
blocks in synthetic and medicinal chemistry.[1] They are usually 
accessed via multi-step ring-forming processes.[2] Since 2007, 
more efficient approaches based on metal-catalyzed direct C-H 
coupling of two (hetero)arenes have been intensively studied, 
especially for the coupling of indoles with electron-neutral or -poor 
(hetero)-arenes.[3-5] However, the direct coupling of indoles with 
electron-rich heterocycles was successful only in the case of 
homo-coupling to form symmetrical bi-indolyl compounds.[6] This 
is an important limitation, as non symmetrical derivatives can be 
found in natural products like Asteropusazole A (1),[7] synthetic 
bioactive molecules like anti-estrogen 2,[8] hole transport materials 
like indole trimer 3,[9] and transition metal ligands like indole 
phosphine 4.[10] 
 
Figure 1. Selected reported compounds containing bi-heteroaryls. 
To access non-symmetrical electron-rich bi-heteroaryls, 
cyclization methods[11] or cross coupling reactions requiring pre-
functionalization of both partners[12] remain most often used.[13] 
The Umpolung of the reactivity of the indole ring to enable 
selective cross-coupling with electron-rich heterocycles is an 
attractive alternative approach (Scheme 1).[14] The protonation of 
3-bromo indole followed by Friedel-Crafts reaction and elimination 
has been reported, but required the use of strong acids (Scheme 
1A).[15] This led to multiple arylation and oligomerization, and 
therefore to a limited scope. Oxidative methods based on 
activation with hypochlorite[16] or sulfonium reagents[17] have been 
successful only for 3-substituted indoles. Kita and co-workers 
have been highly successful in the Umpolung of electron-rich 
benzene rings,[18] pyrroles[19] and thiophenes[20] through the use of 
hypervalent iodine reagents activated by Lewis acids without the 
need for any transition metal catalyst (Scheme 1B).[21] However, 
only very few examples of the Umpolung of indoles were 
reported.[22] In particular, the synthesis of hetero bi-indolyl 
compounds has never been reported. Therefore, there is currently 
no general method for the Umpolung of indoles allowing for 
reaction with electron-rich heterocycles under mild conditions. 
Scheme 1. Umpolung of indoles for accessing non-symmetrical bi-heteroaryls. 
The availability of stable isolable indole-based iodonium 
salts would allow oxidative coupling under more controlled 
conditions. However, these compounds are often not easily 
accessible, unstable or substituted with de-activating electron-
withdrawing substituents.[23] Our group and Yoshikai and co-
workers have introduced more stable indole- and pyrrole 
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benziodoxol(on)es (BX).[24]. Herein, we report the first use of 
these reagents for the oxidative coupling of indoles with electron-
rich heteroarenes under mild, transition metal free conditions, 
resulting in the first general coupling method for accessing hetero 
bi-indolyl compounds (Scheme 1C).  
As benchmark reagent for the optimization process we 
chose 1,3,5-trimethoxy benzene (1) as nucleophile. Using Kita's 
conditions (hexafluoroisopropanol (HFIP) as solvent and 
trimethylsilylbromide as Lewis acid),[19c] but with indoleBX 2a, we 
obtained product 7a in 41% yield (Table 1, entry 1). Bis-arylated 
byproduct 8 was also observed in 17% yield. Interestingly, only 
C2 functionalized indole 7a was obtained starting from C3-
substituted indoleBX 2a, whereas C3-substituted products were 
formed when using transition metal catalysis.[24a-c]  
Table 1. Optimization of the (hetero)arylation on electrophilic heterocycles. 
 
Entry Reagent Reaction Conditions[a] Yield[b] 7a/8 
1 2a 1.5 equiv 2a, 2.0 equiv TMSBr, HFIP 0.1 M 41%/17% 
 
2 2a 1.0 equiv TMSBr, HFIP 0.1 M 44%/12% 
 
3 2a 1.0 equiv TMSCl, HFIP 0.1 M 68%/-% 
 
4 2a 0.5 equiv TMSCl, HFIP 0.1 M 10%/-% 
5 2a 1.5 equiv 2a, 2.0 equiv HCl, HFIP 0.1 M - 
6 2a no HFIP or no TMSCl - 
7 2a 1.0 equiv TMSCl, 10 equiv HFIP, DCM 0.1 M 76%/-% 
8 3a 1.0 equiv TMSCl, 10 equiv HFIP, DCM 0.1 M 22%/ 
9 4a 1.0 equiv TMSCl, 10 equiv HFIP, DCM 0.1 M traces 
10 5 1.5 equiv 4-F-PIDA, 2.0 equiv TMSCl, HFIP 0.1 M 16%[c] 
11 6 1.5 equiv 6, 2.0 equiv. TMSBr, HFIP 0.1 M - 
[a] Reaction performed at 0.10 mmol scale at r.t. using 1.0 equiv indole reagent 
2-6 unless stated otherwise. [b] Isolated yield after purification by column 
chromatography. [c] Yield of 7a given. Oligomers, bis-indoles and indole-
indolines were also detected.  
Importantly, using equimolar amounts of TMSBr and 
reagent 2a did not change the outcome of the reaction (Table 1, 
entry 2). Switching from TMSBr to the milder TMSCl improved the 
yield of the mono-arylated product 7a, and suppressed the 
formation of 8 (Table 1, entry 3). A sub-stoichiometric amount of 
TMSCl led to a lower yield (Table 1, entry 4). Replacing TMSCl 
with HCl didn’t work and both Lewis acid and HFIP were 
necessary for the reaction to proceed (Table 1, entries 5-6). The 
latter is probably needed to stabilize cationic aromatic and 
iodine(III) species.[25] When running the reaction in 
dichloromethane (DCM), 10 equivalents of HFIP were enough to 
give indole 7a in 76% yield (Table 1, entry 7). Only very low yields 
were obtained with benziodoxole reagents 3a and 4a (Table 1, 
entries 8-9). Using 4-fluorophenyl iodobenzene diacetate (4-F-
PIDA) as oxidant together with N-methylindole (5) as reported by 
Kita and co-workers,[19c] afforded 7a in only 16% yield (Table 1, 
entry 10). Oligomers, bis-indoles and indole-indolines resulting 
from homocoupling were also detected in the reaction mixture. A 
control experiment with C3-iodoindole 6 confirmed the necessity 
of iodine(III) as activator (Table 1, entry 11).  
The reaction of different benziodoxolone reagents with 
trimethoxybenzene as nucleophile was then examined (Scheme 
2A). Products 7b and 7c bearing an iodine and a boronic esters 
substituent were obtained in 69 and 54% yield respectively. The 
method is therefore orthogonal to transition-metal catalyzed 
cross-couplings, allowing access to useful functionalities. 
Reagents with a NH-free indole were not successful. Starting from 
C2-methylated indoleBX, C3-arylated indole 7d was accessed in 
40% yield. Arylated pyrroles 7e-f were obtained in yield 
comparable to those reported by Kita and Dohi.[19c] 
 
Scheme 2. Scope of the Lewis acid promoted (hetero)arylation of indoles and 
pyrroles. Reaction conditions; 0.30 mmol nucleophile, 0.30 mmol 
indole/pyrroleBX 2, 0.30 mmol TMSCl, 3.0 mmol HFIP, DCM 0.2 M, r.t. [a] As a 
9:1 mixture of mono-/bi- arylation products. [b] As a 12:1 mixture of C3:C7 
heteroarylation products. [c] As a 1:1 mixture of C2:C3 heteroarylation products. 
With indoles as nucleophiles, we were delighted to obtain 
3’,2 mixed bi-indoles in moderate to good yields, with only minor 
formation of de-aromatization, oligomerization and homo-
coupling side products (Scheme 2B). In addition to homocoupling 
product 8a, mixed bi-indolyls 8b-f bearing electron-donating 
groups, halogens or boronic esters were obtained in 64-72% yield. 
When C6-OBn-methylindole was used, benzyl deprotected 
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product 8g was formed. N-Unprotected indoles afforded products 
8h-j in 61-78% yield. When C3-substituted indoles were used as 
nucleophiles, 2’,3 connected bi-indolyl 8k-l were obtained in 45-
57% yield. Using substituted IndoleBX's allowed to introduce 
functionalities on the other indole ring (products 8m-o). For 
example, bi-indolyls 8e and 8m differ only by the position of the 
iodine atom. This could not have been achieved selectively with 
any previously reported method. Finally, preliminary results with 
pyrroles and thiophenes were also obtained (products 9a-b and 
10a-b respectively, Scheme 1C).  
The synthesis of IndoleBXs developed in our group[24a] did 
not allow access to indoles bearing easily removable nitrogen 
protecting groups or C3 substituents. We therefore developed a 
new synthetic approach for IndoleBXs bearing the iodine atom on 
the C2 position. After intensive screening of indole precursors and 
conditions,[26] we accessed the desired reagents 13 by reacting 
indole trifluoroborate salts 11[27] with fluoro benziodoxol(on)e 12 
(Scheme 3).[28]  Benziodoxolone reagents 13a-b were obtained in 
low yield. IndoleDBX (dimethylbenziodoxole) 13c-d were isolated 
in 86% and 53% yield respectively (the procedure was scalable 
up to two grams for the former). Substituents in C5, C6 and C3, 
including ethers, halogens and protected amines, were well 
tolerated, affording benziodoxoles 13e-i in 63-97% yield.[29] 
Best results in the heteroarylation of trimethoxybenzene (1) 
were obtained with N-Boc protected IndoleDBX reagents using 
TMSBr (Scheme 4). Under these conditions, the Boc group was 
removed, giving NH free indoles 14a-d in 50-94% yield.[30] It was 
now possible to obtain C2-arylated-C3-alkylated indoles 14e and 
14f in 82% and 75% yield respectively. The use of indoles as 
nucleophiles required milder TMSCl as Lewis acid and gave 
access to NH unprotected heterodimers 15a-c in 34-56% yield. 
Thiophene-indole heteroaryl 16 was obtained in 28% yield. 
 
Scheme 3. Synthesis of C2-substituted IndoleBX reagents. 
At this stage, it is difficult to propose a reaction mechanism 
rationalizing the observed regioselectivity. Either a nucleophilic 
(vicarious) aromatic substitution pathway or a single electron 
transfer (SET) from a charge-transfer complex could be 
considered.[18-21] In both cases, Lewis acid activation of the 
hypervalent iodine reagent would initiate the reaction.[31] The 
obtained products could be easily modified (Scheme 5). 
Cyclization of 8j with acetal 17 gave indole-carbazole 18 in 81% 
yield (Scheme 5A).[32] Palladium catalysed oxidative cyclization of 
8d led to the formation of carbazole 20 (Scheme 5B).[33]  Indole-
carbazoles are important sub-structures in optoelectronic 
materials.[9,34] Finally, a Ciamician-Dennstedt rearrangement 
converted indole 14a into quinoline 21 (Scheme 5C).[35] 
 
Scheme 4. Scope of the oxidative heteroarylation using C2-IndoleDBX 
reagents 13. Reaction conditions; 0.22 mmol nucleophile, 0.20 mmol indoleDBX, 
0.40 mmol TMSBr, 2.0 mmol HFIP, DCM 0.2 M, r.t. [a] TMSCl was used instead 
of TMSBr. 
In conclusion, we have reported a straightforward approach for 
the selective synthesis of mixed bi-(hetero)arenes. Electrophilic 
hypervalent iodine reagents (IndoleBX) were combined with 
equimolar amounts of functionalized indole, pyrrole and 
thiophene nucleophiles in a metal-free protocol. Selectively 
functionalized bi-indolyl heterocycles were obtained with high 
efficiency. New C2-IndoleDBXs reagents were synthesized, 
increasing significantly the scope of accessible bi-heterocycles. 
Further investigations are ongoing on the use of benziodoxol(on)e 
reagents in the Umpolung of electron-rich heterocycles. 
Scheme 5. Product derivatizations. 
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under mild metal-free conditions to access hetero-bi-heterocycles in high yields. High 
functional group tolerance set the stage for easy and regioselective post-
functionalization to access more complex heterocyclic systems. 
BX reagents are stable up to 150 °C and can be used for selective heterocycle 
transfer onto the C-H bonds of arenes ortho to directing groups by using rhodium or 
ruthenium catalysts. 
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1. Materials and Methods. 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography, technical grade solvents were used. 
For flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. 
THF, Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina 
under nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). The solvents were 
degassed through Freeze-Pump-Thaw method when mentioned. All chemicals were purchased 
from Acros, Aldrich, Fluka, VWR, Aplichem, or Merck and used as such unless otherwise 
stated. Chromatographic purification was performed as flash chromatography using Macherey-
Nagel silica 40-63, 60 Å, with the solvents indicated as eluent under 0.1-0.5 bar pressure. TLC 
was performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates and visualized 
with UV light, permanganate stain, CAN stain, or Anisaldehyde stain. Melting points were 
measured on a Büchi B-540 melting point apparatus using open glass capillaries, the data is 
uncorrected. 1H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in 
CDCl3, DMSO-d6 CD3OD, C6D6 and CD2Cl2, all signals are reported in ppm with the internal 
chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm the internal methanol 
signal at 3.30 ppm, the internal dichloromethane signal at 5.30 ppm as standard. The data is 
being reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet 
or unresolved, br = broad signal, app = apparent, coupling constant(s) in Hz, integration, 
interpretation).13C-NMR spectra were recorded with 1H-decoupling on a Brucker DPX-400 100 
MHz spectrometer in CDCl3, DMSO-d6, CD3OD or CD2Cl2, all signals are reported in ppm with 
the internal chloroform signal at 77.0 ppm, the internal DMSO signal at 39.5 ppm, the internal 
methanol signal at 49.0 ppm and the internal dichloromethane signal at 54.0 ppm as standard. 
Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer with an ATR 
PRO410-S and a ZnSe prisma and are reported as cm-1 (w = weak, m = medium, s = strong, br 
= broad). High resolution mass spectrometric measurements were performed by the mass 
spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API.  
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2. Preparation of IndoleBXs.  
The synthesis of the precursors for HeterocyclicBX reagents 2a-2f’, 3a, 4a, 13a-13i and their 
starting materials had been already described before.[1,2] The procedures here reported are taken 
from the cited publications to facilitate reproduction of the results by having all the data in the 
same file. Compound 12b is commercially available. 
 
Figure 2.1: Heterocyclic hypervalent iodine reagents precursor. 
2.1 Preparation of Hypervalent Iodine Precursors. 
1-Chloro-1,2-benziodoxol 3(1H)-one (12d): 
 
Following a slightly modified procedure,[3] commercially available 2- iodobenzoic acid 22 
(4.00 g, 16.1 mmol, 1 equiv.) was dissolved in anhydrous MeCN (30 mL). The resulting stirred 
suspension was heated to 75 °C in an oil bath. The dropping funnel was charged with a solution 
of trichloroisocyanuric acid 23 (1.41 g, 6.07 mmol, 1.02 Cl+ equiv.) in 10 mL of anhydrous 
MeCN by syringe. The solution of trichloroisocyanuric acid 23 was dropped into the vigorously 
stirred reaction mixture within 5 min. After addition was complete, the reaction mixture was 
refluxed for an additional 5 min. The reaction mixture was vacuum-filtered over a preheated, 
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sintered-glass funnel with a tightly packed pad of Celite (1 cm thick), and the filter cake was 
rinsed with additional hot MeCN (20-50 mL). The combined filtrates were evaporated to near-
dryness, and the resulting yellow solid was filtered over a sintered-glass funnel and washed 
with a small amount of cold MeCN. The mother liquor from filtration was partially concentrated 
on vacuum, giving a second crop of solids. The combined crops were dried under high vacuum 
to obtain 1-Chloro-1,2-benziodoxol 3(1H)-one 12d (3.16 g, 11.2 mmol, 69% yield) as light 
yellow solid. 1H NMR (400 MHz, Acetone-d6) δ 8.34 – 8.24 (m, 1H), 8.16 (ddd, J = 7.8, 6.5, 
1.8 Hz, 2H), 7.96 – 7.85 (m, 1H). The NMR values correspond to the reported ones.[3] 
1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (12e) 
 
Following a reported procedure,[3] commercially available methyl 2-iodobenzoate 24 (12.0 mL, 
76.0 mmol) was dissolved under N2 atmosphere in dry diethyl ether (400 mL) and then the 
solution was cooled to 0 °C with an ice bath. Methylmagnesium bromide (56.0 mL, 0.168 mol, 
2.20 equiv.) was added dropwise and the reaction was stirred for 30 min at 0 °C. The reaction 
mixture was then allowed to warm to room temperature and it was further stirred for 2 h. The 
reaction was quenched with NH4Cl in an iced bath. The organic layer was separated and 
extracted with Et2O (3 x 100 mL), washed with water (2 x 200 mL), brine (1 x 100 mL) then 
dried over MgSO4. The solvent was removed in vacuo.  
With no further purification the crude mixture was dissolved in CCl4 (7 mL) and tert-butyl 
hypochlorite (100 mL, 92.0 mmol, 1.20 equiv.) and the reaction mixture was stirred at room 
temperature. After one hour a yellow precipitate was collected by filtration and washed with 
hexane (60 mL) to afford compound 12e (7.70 g, 26.0 mmol, 34% yield) as a yellow solid. 1H 
NMR (400 MHz, CDCl3) δ 8.03 (dd, 1 H, J = 8.1, 1.1 Hz, CHAr), 7.55 (m, 2 H, CHAr), 7.17 
(dd, 1 H, J = 7.3, 1.7 Hz, CHAr), 1.55 (s, 6 H, (CH3)2).
 13C NMR (101 MHz, CDCl3) δ 149.5, 
131.0, 130.5, 128.4, 126.1, 114.7, 85.2, 29.2.  IR ν 3729 (w), 3626 (w), 2972 (w), 2924 (w), 
2362 (w), 2055 (w), 2018 (w), 1742 (w), 1564 (w), 1464 (w), 1439 (w), 1379 (w), 1378 (w), 
1366 (w), 1277 (w), 1276 (w), 1256 (w), 1181 (w), 1154 (m), 1112 (w), 1048 (w), 1003 (w), 
982 (w), 943 (m), 866 (m), 808 (w), 790 (w), 789 (w), 762 (s), 745 (w), 724 (w), 718 (w). The 
characterization data is in accordance with reported literature values.[4] 
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1-Chloro-1,3-dihydro-3,3-bis(trifluoromethyl)-1,2-benziodoxole (12f)  
 
Following a reported procedure, TMEDA (distilled over KOH) (1.26 mL, 8.20 mmol, 0.200 
equiv) was added to a solution of nBuLi (2.5 M in hexanes, 36.6 mL, 91.6 mmol, 2.20 equiv). 
After 15 min, the cloudy solution was cooled to 0 °C and 25 (7.00 mL, 42.0 mmol, 1 equiv) in 
THF (6 mL) was added dropwise. The reaction was stirred 30 min at 0 °C and then at RT 
overnight. I2 (11.2 g, 44.0 mmol, 1.06 equiv) was then added portionwise at 0 °C and the 
mixture stirred at 0 °C for 30 min and 4 h at RT. The reaction was quenched with saturated 
NH4Cl. Et2O (100 mL) was added and the layers were separated. The aqueous layer was then 
extracted twice with Et2O (3 x 50 mL). The organic layers were combined, washed twice with 
saturated NaS2O3 (2 x 50 mL), dried over MgSO4, filtered and concentrated under reduced 
pressure to afford 15.6 g of crude 26 as an brown oil which was used without further 
purification. The crude oil was dissolved in MeCN (40 mL) in the dark under air. 
Trichloroisocyanuric acid 23 (3.42 g, 14.3 mmol, 0.340 equiv.) was then added portionwise at 
r.t. After 30 min, the resulting suspension was filtered to afford 12f (7.30 g, 18.1 mmol, 43%) 
as a yellow solid. The mother liquors were carefully reduced to one third and filtered to afford 
more xx (8.85 g, 21.9 mmol, 52.1% yield) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 
8.09 (d, 1 H, J = 8.4 Hz, ArH), 7.85 (m, 1 H, ArH), 7.73 (m, 2 H, ArH). 13C NMR (101 MHz, 
CDCl3) δ 133.8, 132.1, 131.6, 129.7, 128.5, 122.8 (q, 289 Hz), 113.4, 84.8. The melting point 
and the 1H NMR correspond to the reported values.[5]  
 
Synthesis of 1-Acetoxy-1,2-benziodoxol-3-(1H)-one (12g) 
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Following a reported procedure,[1] NaIO4 (7.24 g, 33.8 mmol, 1.05 equiv) and 2-iodobenzoic 
acid 22  (8.00 g, 32.2 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH (48 mL). The 
mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was then diluted with 
cold water (180 mL) and allowed to cool to room temperature, protecting it from light. After 1 
h, the crude product was collected by filtration, washed on the filter with ice water (3 x 20 mL) 
and acetone (3 x 20 mL), and air-dried in the dark to give the pure hydroxylated intermediate 
12c. 
Following a reported procedure,[3] hydroxylated intermediate 12c (39.1 mmol, 1.00 equiv.) was 
suspended in acetic anhydride (35 mL) and heated to reflux for 5 minutes, up to dissolution of 
the starting material. The resulting clear, slightly yellow solution was slowly let to cool down 
to room temperature and then cooled to 0 °C for 30 minutes. The white suspension was filtered 
and the filtrate was again cooled to 0 °C for 30 minutes. The suspension was once again filtered 
and the combined two batches of solid product were washed with hexane (2 x 20 mL) and dried 
in vacuo to afford product 12g. 1-Acetoxy-1,2-benziodoxol-3-(1H)-one 12g (10.8 g, 35.3 
mmol, 90%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ 8.24 (dd, J = 7.6, 1.6 Hz, 1H, 
ArH), 8.00 (dd, J = 8.3, 1.0 Hz, 1H, ArH), 7.92 (ddd, J = 8.4, 7.2, 1.6 Hz, 1H, ArH), 7.71 (td, 
J = 7.3, 1.1 Hz, 1H, ArH), 2.25 (s, 3 H, COCH3). 13C NMR (CDCl3, 100 MHz) δ 176.5, 168.2, 
136.2, 133.3, 131.4, 129.4, 129.1, 118.4, 20.4. NMR values are in accordance with the data 
reported in literature.[6] 
 
1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (12h) 
 
Following a reported procedure,[3] 1-chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole 12d 
(2.60 g, 8.77 mmol) was dissolved in dry acetonitrile (25 mL) under N2 atmosphere. The 
reaction flask was covered with aluminum foils and protected from light. Silver acetate (1.46 
g, 8.77 mmol, 1.00 equiv.) was then added in one portion. The reaction mixture was stirred in 
the dark at room temperature for 16 h. Filtration over a Celite plug and evaporation of the 
solvent yielded compound 12h (2.6 g, 8.8 mmol, 93%) as a brownish solid. 1H NMR (400 
MHz, CDCl3) δ 7.79 (dd, 1 H, J = 8.0, 1.3 Hz, CHAr), 7.47 (m, 2H, CHAr), 7.18 (dd, 1 H, J = 
7.2, 1.7 Hz, CHAr), 2.11 (s, 3 H, COCH3), 1.52 (s, 6 H, (CH3)2).  13C NMR (101 MHz, CDCl3) 
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δ 177.4, 149.4, 130.4, 130.0, 129.9, 126.2, 115.7, 84.6, 29.2, 21.5.  IR ν 3099 (w), 3057 (w), 
2975 (w), 2930 (w), 2930 (w), 2865 (w), 1740 (w), 1640 (s), 1588 (w), 1566 (w), 1462 (w), 
1438 (m), 1363 (s), 1294 (s), 1259 (m), 1158 (m), 1114 (w), 1047 (w), 1033 (w), 1009 (w), 949 
(m), 926 (w), 866 (w), 761 (s), 723 (w).  The characterization data is in accordance with reported 
literature values.[3] 
 
 
1-Acetoxy-1,3-dihydro-3,3-bis(trifluoromethyl)-1,2-benziodoxole (12i) 
 
1-Chloro-1,3,-dihydro-3,3-bis(trifluoromethyl)-1,2-benziodoxole 12f (8.85 g, 21.9 mmol) and 
AgOAc (3.65 g, 21.9 mmol, 1.00 equiv.) were suspended in MeCN (109 mL, 0.2 M). After 
being stirred overnight in the dark, AgCl precipitated and was filtered off. The residue was 
washed with MeCN. The solvent was removed in vacuo to give 12i (9.37 g, 21.9 mmol, 100%) 
as a white solid. 1H NMR (300 MHz, CDCl3) δ  7.93 (d, J = 8.4 Hz, 1H, ArH), 7.61–7.79 (m, 
3H, ArH), 2.18 (s, 3H, CH3). The NMR values correspond to the reported ones.
[6] 
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2.2 Preparation of N-carbamoylated and -tosylated indoles and their trifluoroborate 
salts. 
In this section, only the synthesis of non-commercially available indole compounds is reported. 
The synthesis of the precursors for HeterocyclicBX reagents 13a-13i had been already 
described by our group before. The procedures reported here are taken from the cited 
publications to facilitate reproduction of the results by having all the data in the same file.[7,8] 
General Procedure GP1 for the N-Carbamoylation of Indoles. 
 
Following a reported procedure,[9] to a solution of commercially available 1H-indoles (10.0 
mmol, 1.00 equiv.) and N,N-dimethylaminopyridine (122 mg, 1.00 mmol, 0.100 equiv) in 0.5 
M CH2Cl2, di-tert-butyl dicarbonate (2.40 g, 11.0 mmol, 1.10 equiv.) was added under vigorous 
stirring at 0 °C. The reaction was then allowed to stir at room temperature overnight. Brine (50 
mL) and CH2Cl2 (30 mL) were added to the reaction mixture and the organic layer extracted. 
The aqueous layer was further extracted with CH2Cl2 (2 x 50 mL). The combined organic layers 
were dried over MgSO4 concentrated in vacuum and the crude was directly submitted to short-
path flash chromatography (Pentane: EtOAc: 95:5) to afford the desired N-Boc indole 
derivatives 27a-27e. 
 
Figure 2.2 N-carbamoylated indoles. 
 
Tert-butyl 1H-indole-1-carboxylate (27a) 
Following the general procedure GP1 (synthesis of tert-butyl 1H-indole-1-
carboxylate was scaled up to 20.0 mmol without reoptimization of the protocol.), 
starting from commercially available 1H-indole (2.34 g, 20.0 mmol, 1.00 equiv.), 
after 16 hours tert-butyl 1H-indole-1-carboxylate 27a  was obtained as colorless oil (3. 90 g, 
17.9 mmol, 90% yield). Rf: 0.8 (Pentane: EtOAc 9:1) 1H NMR (400 MHz, CDCl3) δ 8.36 (d, J 
= 8.5 Hz, 1H, ArH), 7.74 (d, J = 3.8 Hz, 1H, ArH), 7.69 (dt, J = 7.7, 1.0 Hz, 1H, ArH), 7.47 
(ddd, J = 8.4, 7.1, 1.3 Hz, 1H, ArH), 7.37 (td, J = 7.5, 1.1 Hz, 1H, ArH), 6.68 (d, J = 3.8 Hz, 
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1H, ArH), 1.79 (s, 9H, C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 149.5, 135.0, 130.3, 125.6, 
123.9, 122.4, 120.7, 114.9, 107.1, 83.2, 27.9. The NMR values correspond to the reported 
ones.[9] 
Tert-butyl 5-methoxy-1H-indole-1-carboxylate (27b) 
Following general procedure GP1, starting from commercially available 5-
methoxy-1H-indole (1.47 g, 10.0 mmol), after 14 hours tert-butyl 5-
methoxy-1H-indole-1-carboxylate 27b (1.92 g, 7.80 mmol, 78% yield) was 
obtained as a colorless solid. Rf: 0.8 (Pentane: EtOAc 95:5). 1H NMR (400 MHz, CDCl3) δ 
8.06 (d, J = 9.1 Hz, 1H, ArH), 7.59 (d, J = 3.6 Hz, 1H, ArH), 7.04 (d, J = 2.6 Hz, 1H, ArH), 
6.96 (dd, J = 9.0, 2.6 Hz, 1H, ArH), 6.51 (d, J = 3.7 Hz, 1H, ArH), 3.86 (s, 3H, OCH3), 1.68 (s, 
9H, C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 155.7, 149.6, 131.3, 129.8, 126.4, 115.7, 112.9, 
107.1, 103.4, 83.4, 55.5, 28.1. The NMR values correspond to the reported ones.[10] 
Tert-butyl 6-methoxy-1H-indole-1-carboxylate (27c) 
Following general procedure GP1, starting from commercially available 6-
methoxy-1H-indole (1.47 g, 10.0 mmol), after 12 hours tert-butyl 6-
methoxy-1H-indole-1-carboxylate 27c (2.23 g, 9.02 mmol, 90% yield) was 
obtained as a colorless solid. Rf: 0.8 (Pentane: EtOAc 9:1).1H NMR (400 MHz, CDCl3) δ 7.75 
(s, 1H, ArH), 7.47 (d, J = 3.7 Hz, 1H, ArH), 7.42 (d, J = 8.6 Hz, 1H, ArH), 6.87 (dd, J = 8.5, 
2.4 Hz, 1H, ArH), 6.49 (dd, J = 3.7, 0.8 Hz, 1H, ArH), 3.88 (s, 3H, OCH3), 1.67 (s, 9H, 
C(CH3)3).13C NMR (101 MHz, CDCl3) δ 157.6, 149.8, 136.1, 124.5, 124.2, 121.2, 112.1, 107.1, 
99.2, 83.4, 55.6, 28.8. NMR values correspond to the reported ones.[11] 
 
Tert-butyl 6-bromo-1H-indole-1-carboxylate (27d) 
 Following general procedure GP1, starting from commercially available 6-
bromo-1H-indole (2.00 g, 10.2 mmol), after 16 hours tert-butyl 6-bromo-1H-
indole-1-carboxylate 27d (2.94 g, 9.93 mmol, 97% yield) was obtained as a 
white solid. Rf: 0.7 (Pentane: EtOAc 9:1) 1H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H, ArH), 
7.56 (d, J = 3.7 Hz, 1H, ArH), 7.41 (d, J = 8.3 Hz, 1H, ArH), 7.34 (dd, J = 8.3, 1.8 Hz, 1H, 
ArH), 6.56 – 6.50 (m, 1H, ArH), 1.68 (s, 9H, C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 149.3, 
135.8, 129.2, 126.2, 125.8, 121.9, 118.3, 117.8, 106.9, 84.1, 28.1. NMR values correspond to 
the reported ones.[12] 
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Tert-butyl 3-methyl-1H-indole-1-carboxylate (27e) 
 Following general procedure GP1, starting from commercially available 3-
methyl-1H-indole (1.31 g, 9.99 mmol), after 16 hours tert-butyl 6-bromo-1H-
indole-1-carboxylate 27e (2.00 g, 8.65 mmol, 87% yield) was obtained as a 
colorless liquid. Rf: 0.9 (Pentane: EtOAc 95:5). 1H NMR (400 MHz, CDCl3) 
δ 8.16 (br-s, 1H, ArH), 7.53 (d, J = 7.6 Hz, 1H, , ArH), 7.39 (s, 1H, ArH), 7.35 (ddd, J = 8.3, 
7.2, 1.4 Hz, 1H, ArH), 7.31 – 7.24 (m, 1H, ArH), 2.31 (s, 3H, CH3), 1.70 (s, 9H, C(CH3)3). 13C 
NMR (101 MHz, CDCl3) δ 149.5, 135.3, 131.2, 123.9, 122.5, 122.1, 118.6, 116.0, 114.9, 82.7, 
27.9, 9.3. NMR values correspond to the reported ones.[13] 
Synthesis of 1-Tosyl-1H-indole (30) 
 
Following a reported procedure[14] to a solution of the commercially available NH-indole 28 
(3.52 g, 30.0 mmol, 1.00 equiv.) in anhydrous DCM (0.10 M, 300 mL) was added nBu4NHSO4 
(1.02 g, 3.00 mmol, 0.100 equiv.) followed by addition of freshly powdered NaOH (4.81 g, 120 
mmol, 4.00 equiv.). The resultant solution was allowed to stir at room temperature for 10 
minutes before addition of 4-methylbenzene-1-sulfonyl chloride 29 (11.4 g, 60.0 mmol, 2.00 
equiv.) and then allowed to stir at room temperature. After 3 hours, the reaction was quenched 
with H2O (equal amount to reaction solvent volume), the organic layer was collected, and the 
aqueous layer was extracted three times with CH2Cl2 (equal to reaction volume). The combined 
organic layers were dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. The crude product was then purified via flash column chromatography and 1-tosyl-
1H-indole 30 (6.20 g, 22.8 mmol, 76% yield) was obtained as a colorless solid. Rf: 0.6 (Pentane: 
EtOAc 8:2). 1H NMR (400 MHz, CDCl3) δ 8.01 (dd, J = 8.3, 0.9 Hz, 1H, ArH), 7.83 – 7.75 
(m, 2H, ArH), 7.58 (d, J = 3.6 Hz, 1H, ArH), 7.53 (dt, J = 7.8, 1.0 Hz, 1H, ArH), 7.32 (ddd, J 
= 8.4, 7.2, 1.3 Hz, 1H, ArH), 7.24 (dd, J = 7.8, 1.0 Hz, 1H, ArH), 7.22 – 7.16 (m, 2H, ArH), 
6.66 (dd, J = 3.7, 0.8 Hz, 1H, ArH), 2.32 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 144.8, 
135.2, 134.7, 130.6, 129.8, 126.7, 126.2, 124.4, 123.2, 121.3, 113.4, 108.9, 21.4. The NMR 
values correspond to the reported ones.[14] 
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Synthesis of 2-(2-(1H-Indol-3-yl)ethyl)isoindoline-1,3-dione (33) 
 
Following the reported procedure,[15] a mixture of commercially available tryptamine 31 (1.00 
g, 6.24 mmol) and phthalic anhydride 32 (1.02 g, 6.80 mmol) in toluene (25 mL) was refluxed 
overnight (the reaction was completed as judged by TLC (Pentane: EtOAc 3:2)). The reaction 
mixture was cooled to room temperature and the solution was concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel to get 2-(2-(1H-indol-3-
yl)ethyl)isoindoline-1,3-dione 33 (1.60 g, 5.50 mmol, 88% yield) as a yellow solid. Rf: 0.6 
(Pentane: EtOAc 2:3). 1H NMR (400 MHz, CDCl3) δ 8.09 (br-s, 1H, NH), 7.83 (dd, J = 5.4, 
3.1 Hz, 2H, ArH), 7.77 – 7.66 (m, 3H, ArH), 7.35 (d, J = 8.1 Hz, 1H, ArH), 7.22 – 7.03 (m, 3H, 
ArH), 4.07 – 3.96 (m, 2H, NCH2), 3.16 (dd, J = 8.9, 6.7 Hz, 2H, C-CH2).13C NMR (101 MHz, 
CDCl3) δ 168.3, 136.2, 133.8, 132.1, 127.3, 123.1, 122.1, 122.0, 119.5, 118.8, 112.3, 111.1, 
38.5, 24.4. The NMR values correspond to the reported ones.[16] 
General Procedure GP2 for the Borylation of N-Boc-Indoles. 
 
With a slight modification of the reported procedure,[17] 2,2,6,6-tetramethylpiperidine (1.30 
equiv.) in anhydrous THF (0.40 M) was cooled to -78 °C under an atmosphere of argon and 
treated dropwise with n-BuLi in Hexane (1.50 equiv.). The mixture was stirred at -78 °C for 10 
min, then a solution of the corresponding 1-(tert-butoxycarbonyl)-1H-indole 27a-27e (1.00 
equiv.) in THF (1.00 M) was added dropwise. The mixture was stirred at -78 °C for 45 min. 
B(Oi-Pr)3 (3.00 equiv.) was added dropwise, and the reaction mixture was stirred for 30 min at 
-78 °C before being warmed to r.t. The reaction mixture was quenched with H2O (30 mL), 
slowly acidified with 10% HCl at 0 °C (pH: 6), and extracted with EtOAc (3 times). The 
combined organic layers were washed with brine, dried over MgSO4, and the solvent was 
removed under vacuum. In the next step, without further purification, the crude product was 
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dissolved in MeOH (0.20 M) and cooled at 0° C. Then a 4.5 M aqueous solution of KHF2 (3.00 
equiv.) was slowly added and the reaction mixture was stirred for 4 hours until the clear solution 
turned to a thick suspension. The solid was then filtered and washed with a minimum of cold 
MeOH (2 mL). The solid was dried on a high-vacuum line to afford the corresponding trifluoro 
borate salts 11a-11e. 
 
Figure 2.3 Indole-C2-trifluoroborate potassium salts. 
Potassium trifluoro(1-tert-butoxycarbonyl-1H-indol-2-yl)borate (11a) 
Following general procedure GP2, starting from synthesized 1-(tert-
butoxycarbonyl)-1H-indole 27a (4.50 g, 20.7 mmol., 1.00 equiv.) with 
commercially available 2,2,6,6-tetramethylpiperidine (4.60 mL, 27.0 
mmol. 1.30 equiv.), 2.5 M n-BuLi in hexane (12.4 mL, 31.1 mmol, 1.50 
equiv.), triisopropyl borate (14.3 mL, 62.1 mmol, 3.00 equiv.) and 4.5 M aqueous solution of 
KHF2 (13.8 mL, 62.0 mmol, 3.00 equiv.) Potassium trifluoro(1-tert-butoxycarbonyl-1H-indol-
2-yl)borate (5.20 g, 16.1 mmol, 78% yield) 11a was obtained as colorless solid. 1H NMR (400 
MHz, DMSO-d6) δ 8.02 (dq, J = 8.3, 0.9 Hz, 1H, ArH), 7.47 – 7.31 (m, 1H, ArH), 7.22 – 7.03 
(m, 2H, ArH), 6.46 (s, 1H, ArH), 1.59 (s, 9H, C(CH3)3).13C NMR (101 MHz, DMSO-d6) δ 
151.3, 137.4, 130.7, 121.7, 121.3, 119.3, 114.6, 111.7, 81.5, 27.7. The NMR values correspond 
to the reported ones.[17] NB: the Carbon-Boron bond is not observed as reported in literature.[18] 
 
 
Potassium trifluoro(1-(tert-butoxycarbonyl)-5-methoxy-1H-indol-2-yl)borate (11b) 
Following general procedure GP2, starting from synthesized tert-butyl 5-methoxy-1H-indole-
1-carboxylate 27b (1.50 g, 6.00 mmol, 1.00 equiv.), with commercially available 2,2,6,6-
tetramethylpiperidine (1.33 mL, 7.89 mmol. 1.30 equiv.), 1.6 M n-BuLi in hexane (5.70 mL, 
9.10 mmol, 1.50 equiv.) triisopropyl borate (4.20 mL, 18.2 mmol, 3.00 equiv.) and 4.5 M 
aqueous solution of KHF2 (4.02 mL, 18.1 mmol, 3.00 equiv.) Potassium trifluoro(1-(tert-
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butoxycarbonyl)-5-methoxy-1H-indol-2-yl)borate  11b (1.18 g, 3.34 
mmol, 55% yield). 1H NMR (400 MHz, CD3CN) δ 7.56 (d, J = 9.0 
Hz, 1H, ArH), 6.64 (d, J = 2.6 Hz, 1H, ArH), 6.44 (dd, J = 9.0, 2.6 
Hz, 1H, ArH), 6.30 – 6.16 (m, 1H, ArH), 3.47 (s, 3H, OCH3), 1.33 
(s, 9H, C(CH3)3).13C NMR (101 MHz, CD3CN) δ 156.1, 152.2, 133.2, 132.9, 116.7, 113.7, 
111.4, 103.1, 83.2, 55.8, 28.2. The NMR values correspond to the reported ones.[11] NB: the 
Carbon-Boron bond is not observed as reported in literature.[18] 
 
Potassium trifluoro(1-(tert-butoxycarbonyl)-6-methoxy-1H-indol-2-yl)borate (11c) 
Following general procedure GP2, starting from synthesized tert-
butyl 6-methoxy-1H-indole-1-carboxylate 27c (650 mg, 2.63 mmol, 
1.00 equiv.), with commercially available 2,2,6,6-
tetramethylpiperidine (582 L, 3.42 mmol. 1.30 equiv.), 2.5 M n-BuLi in hexane (1.58 mL, 3.94 
mmol, 1.50 equiv.), triisopropyl borate (1.82 mL, 7.89 mmol, 3.00 equiv.) and 4.5 M aqueous 
solution of KHF2 (1.75 mL, 7.89 mmol, 3.00 equiv.). Potassium trifluoro(1-(tert-
butoxycarbonyl)-6-methoxy-1H-indol-2-yl)borate 11c (813 mg, 2.30 mmol, 88% yield) was 
obtained as colorless solid. M.p. 185 °C, decomposition). 1H NMR (400 MHz, Acetone-d6) δ 
7.65 (d, J = 2.3 Hz, 1H, ArH), 7.25 (d, J = 8.4 Hz, 1H, ArH), 6.72 (dd, J = 8.4, 2.3 Hz, 1H, 
ArH), 6.54 (s, 1H, ArH), 3.79 (s, 3H, OCH3), 1.68 (s, 9H, C(CH3)3). 13C NMR (101 MHz, 
Acetone-d6) δ 157.2, 152.4, 139.4, 126.4, 120.4, 113.5, 111.0, 101.2, 82.8, 55.6, 28.4. IR ν  
2976 (w), 1730 (m), 1699 (m), 1619 (w), 1484 (m), 1440 (w), 1368 (s), 1222 (m), 1200 (s), 
1147 (s), 1092 (s), 1004 (s), 920 (s), 843 (s), 778 (m). HR-ESI-MS: calcd for C14H16BF3NO3
+ 
314.1175 [M - K]+; found 314.1187. NB: the Carbon-Boron bond is not observed as reported 
in literature.[18] 
Potassium trifluoro(1-(tert-butoxycarbonyl)-6-bromo-1H-indol-2-yl)borate (11d) 
Following general procedure GP2, starting from synthesized tert-butyl 
6-bromo-1H-indole-1-carboxylate 27d (1.50 g, 5.06 mmol, 1.00 
equiv.), with commercially available 2,2,6,6-tetramethylpiperidine 
(1.12 mL, 6.58 mmol. 1.30 equiv.), 2.5 M n-BuLi in hexane (3.04 mL, 7.60 mmol, 1.50 equiv.) 
triisopropyl borate (3.51 mL, 15.2 mmol, 3.00 equiv.) and 4.5 M aqueous solution of KHF2 
(3.38 mL, 15.2 mmol, 3.00 equiv.). Potassium trifluoro(1-(tert-butoxycarbonyl)-6-bromo-1H-
indol-2-yl)borate 11d (0.830 g, 2.06 mmol, 41% yield) was obtained as colorless solid. M.p: 
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200 °C, decomposition. 1H NMR (400 MHz, Acetone-d6) δ 8.26 (d, J = 1.9 Hz, 1H, ArH), 7.36 
(d, J = 8.2 Hz, 1H, ArH), 7.23 (dd, J = 8.2, 1.8 Hz, 1H, ArH), 6.63 (d, J = 0.8 Hz, 1H, ArH), 
1.69 (s, 9H, C(CH3)3). 13C NMR (101 MHz, Acetone-d6) δ 152.0, 139.4, 131.4, 125.1, 121.6, 
119.0, 115.7, 113.2, 83.5, 28.2 IR ν 1737 (w), 1709 (w), 1448 (w), 1357 (m), 1325 (s), 1247 
(w), 1211 (w), 1126 (s), 987 (s), 837 (w). HR-ESI-MS: calcd for C13H13B
79BrF3NO2
+ 362.0175 
[M - K]+; found 362.0180. NB: the Carbon-Boron bond is not observed as reported in 
literature.[18] 
Potassium trifluoro(1-(tert-butoxycarbonyl)-3-methyl-1H-indol-2-yl)borate (11e) 
Following general procedure GP2, starting from synthesized tert-butyl 6-
methoxy-1H-indole-1-carboxylate 27e (2.00 g, 8.65 mmol, 1.00 equiv.), 
with commercially available 2,2,6,6-tetramethylpiperidine (1.91 mL, 11.2 
mmol. 1.30 equiv.), 2.5 M n-BuLi in hexane (5.20 mL, 12.9 mmol, 1.50 
equiv.), triisopropyl borate (6.00 mL, 25.9 mmol, 3.00 equiv.) and 4.5 M aqueous solution of 
KHF2 (5.80 mL, 25.9 mmol, 3.00 equiv.). Potassium trifluoro(1-(tert-butoxycarbonyl)-3-
methyl-1H-indol-2-yl)borate 11e (2.50 g, 7.40 mmol, 86% yield) was obtained as colorless 
solid, (Mp: 205 °C). 1H NMR (400 MHz, Acetone-d6) δ 7.96 – 7.86 (m, 1H, ArH), 7.48 – 7.34 
(m, 1H, ArH), 7.19 – 6.99 (m, 2H, ArH), 2.34 (s, 3H, CH3), 1.66 (s, 9H, C(CH3)3). 13C NMR 
(101 MHz, Acetone-d6) δ 152.4, 137.8, 133.8, 122.9, 121.8, 121.1, 118.3, 115.5, 82.6, 28.3, 
10.3.IR ν 2977 (w), 1726 (s), 1454 (w), 1374 (m), 1327 (s), 1238 (m), 1135 (s), 956 (s), 874 
(m), 740 (s). HR-ESI-MS: calcd for C14H16BF3NO2
+ 298.1226 [M - K]+; found 298.1230. NB: 
the Carbon-Boron bond is not observed as reported in literature.[18] 
Synthesis of potassium trifluoro(1-(tosyl)-1H-indol-2-yl)borate (11f) 
 
Following a reported procedure,[19] 1.6 M nBuLi in hexane (9.38 mL, 15.0 mmol, 1.5 equiv.) 
was added dropwise to a solution of N-tosyl-1H-indole 30 (2.71 g, 10.0 mmol, 1.00 equiv) 50 
mL of tetrahydrofuran at -78 °C. The reaction mixture was heated to room temperature and 
stirred for an additional 20 minutes. After cooling to -78 °C., triisopropyl borate (3.92 mL 17.0 
mmol, 1.70 equiv) was added. After 10 minutes of addition, the reaction was allowed to warm 
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to room temperature and stirred overnight. The reaction mixture was quenched with H2O (30 
mL), slowly acidified with 10% HCl at 0 °C (pH:6), and extracted with EtOAc (3 x 50 mL). 
The combined organic layers were dried over magnesium sulfate and evaporated under reduced 
pressure to give 3.15 g of a green oil. The crude product was used without further purification 
in the next reaction. The crude product was dissolved in MeOH (100 mL) and cooled to 0 °C. 
A 4.5 M solution of KHF2 in H2O (6.6 mL, 30 mmol, 3 equiv.) was slowly added and the 
resulting pink thick suspension was stirred at r.t. for 4 hours. The solid was filtered and dried 
under reduced pressure and washed with a minimum of cold MeOH (3 mL). The solid was dried 
on a high-vacuum line to afford the corresponding trifluoro borate salt potassium trifluoro(1-
(tosyl)-1H-indol-2-yl)borate 11f (1.65 g, 4.40 mmol, 44% yield) as colorless solid. M.p. 235 
°C. 1H NMR (400 MHz, Acetone-d6) δ 8.07 (dd, J = 8.8, 3.1 Hz, 3H, ArH), 7.39 – 7.25 (m, 
1H, ArH), 7.14 (d, J = 8.1 Hz, 2H, ArH), 7.11 – 6.99 (m, 2H, ArH), 6.45 (d, J = 0.8 Hz, 1H, 
ArH), 2.22 (s, 3H, CH3). 13C NMR (101 MHz, Acetone-d6) δ 144.2, 138.9, 138.4, 132.7, 129.8, 
128.3, 122.9, 122.8, 120.6, 116.8, 115.2, 21.3. IR ν  2040 (w), 1834 (w), 1417 (s), 1217 (s), 
853 (w). HR-ESI-MS: calcd for: Calcd for C15H12BF3NO2S
+ 338.0634[M - K]+; Found 
338.0626. NB: the Carbon-Boron bond is not observed las reported in literature.[18] 
Synthesis and characterization of tryptamine trifluoroborates (11g) 
 
Following a reported procedure,[20] a flame dried 20-mL pressure flask was charged with (1,5-
cyclooctadiene)(methoxy)iridium(I) dimer (17.0 mg, 30.0 µmol, 1.50 mol%), 4,4'-di-tert-butyl-
2,2'-dipyridyl (14.0 mg, 50.0 µmol, 3.00 mol%), bis(pinacolato)diboron (868 mg, 3.42 mmol, 
2.00 equiv.), N,N-phthaloyltryptamine 33 (500  mg, 1.72 mmol), and a stirring bar and sealed 
with a septum under an atmosphere of argon. Anhydrous dichloromethane (11 mL) was added 
via syringe to give a colorless suspension. The septum was replaced with the pressure flask’s 
Teflon seal and the entire mixture was heated in an oil bath set to 65 °C. After completion of 
reaction (checked by TLC; Pentane: EtOAc 7:3), the reaction mixture is filtered through a small 
silica path and evaporate to dryness. The crude reaction mixture was used for the next step. The 
crude product was dissolved in 10 mL MeOH, and cooled at 0 °C, then a 4.5 M solution of 
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KHF2 (1.20 mL, 5.20 mmol) was slowly added, and the reaction mixture was stirred for 4 hours 
until the clear solution turned thick. The solid was filtered and dried under reduced pressure 
and washed with a minimum of cold MeOH. The solid was dried on a high-vacuum line to 
afford as potassium trifluoro(2-(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione) borate 11g (523 
mg, 1.32 mmol, 77%) as yellow solid. M.p. 210 °C, decomposition. 1H NMR (400 MHz, 
DMSO-d6) δ 9.90 (s, 1H, NH), 7.90 – 7.74 (m, 4H, ArH), 7.46 (d, J = 7.6 Hz, 1H, ArH), 7.23 
(d, J = 7.7 Hz, 1H, ArH), 6.81 (dt, J = 20.5, 7.1 Hz, 2H, ArH), 3.74 (q, J = 9.0, 8.3 Hz, 2H, 
NCH2), 3.04 (t, J = 7.8 Hz, 2H, NCH2-CH2-). 13C NMR (101 MHz, DMSO-d6) δ 167.9, 136.5, 
134.1, 131.8, 129.1, 122.8, 118.3, 116.8, 116.7, 111.0, 110.6, 39.1, 24.6. IR ν 3431 (w), 1705 
(m), 1616 (m), 1399 (w), 1325 (m), 1137 (s), 959 (s), 742 (s). HR-ESI-MS: calcd for 
C18H13BF3K0N2O2
+ 357.1022 [M - K]+; found 357.1028. NB: the Carbon-Boron bond is not 
observed as reported in literature.[18] 
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2.3 Optimization of the synthesis of C2-IndoleBX. 
 
 
Entry X R 
Hypervalent 
reagent (Y,Z) 
Promoter 
(mol%) 
Solvents Yielda 
1 BF3K Boc 12c Zn(OTf)2 DCM -
b 
2  BF3K Boc 12f Zn(OTf)2 DCM -
b 
3  BF3K Boc 12c ZnF2 DCM - 
4  BF3K Boc 12f ZnF2 DCM - 
5  BF3K Boc 12c TfOH DCM -
b 
6  BF3K Boc 12f TfOH DCM -
b 
7  SiMe3 H 12c TMSOTf MeCN - 
8  BF3K Boc 12ac NaBF4 MeCN 27%d,e 
9 BF3K Boc 12e NaBF4 MeCN 86%d,e 
10 SiMe3 Me 12e NaBF4 MeCN, -e,f 
11 BF3K Boc 12e AgBF4 MeCN, -b,f 
12 BF3K Boc 12d AgBF4 MeCN -b,f 
a) Substrate (0.25 mmol), hypervalent iodine reagent 12a-12d, 12g-12h (0.25 mmol), Promoter (20 mol%.) and 
solvent (0.05 M) at 25 °C. all reactions are carried out overnight (except entry 8: carried out for 30 h; entry 9: best 
yield was observed only in 2 hours) b) Degradation of reagent, no expected product was observed. c) This reagent 
was prepared in situ d) Isolated yield after flash chromatography is given. e) Entries 8-10, reactions were quenched 
with 5% aqueous NaBF4 solution. f) Entries 10-12, the reaction initially run at room temperature, no consumption 
of starting material was observed after 6 h then reactions were allowed to refluxing temperature for additional 12 
h 
  
S18 
 
2.4 Preparation of PyrroleBX and IndoleBX Reagents. 
General Procedure GP3 for the Synthesis of C3-Heterocyclic-BX Reagents 2a-2f. 
 
Note: prior to the reaction, the glassware requires to be carefully cleaned with aqua regia to 
remove all metal traces; the commercially available heterocyclic starting material were 
purified through a short plug of silica prior to being used. 
 
GP3:  for 1.00 mmol: in an open air flask, the corresponding heterocycle (1.00 mmol, 1.00 
equiv.), freshly prepared acetoxy-benziodoxolone 12f (1.10 mmol, 1.10 equiv.) and Zinc(II) 
trifluoromethanesulfonate (72.7 mg, 0.200 mmol, 20 mol%.) were dissolved in DCM (20 mL, 
0.05 M). The reaction was stirred while being monitored by TLC (Pentane:EtOAc 9:1 for the 
starting materials, DCM:MeOH 9:1 for the products). Upon consumption of the starting 
material, the crude product was directly submitted to short-path flash chromatography 
(DCM:MeOH 10:1) to afford the desired Heterocyclic-BX compounds 2a-2f. 
 
1-(3-1-Methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2a)  
The synthesis of 1-(3-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 2a was scaled up to 10 mmol without reoptimization of the 
protocol. 
Following procedure GP3: starting from commercially available 1-
methyl-1-H-indole 5 (1.35 g, 10.0 mmol), after 16 hours 1-(3-1-methyl-
1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 2a (3.28 g, 8.70 mmol, 87% yield) was obtained 
as a brown foam. Rf: 0.4 (DCM:MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.40 (dd, J = 7.5, 
1.7 Hz, 1H, ArH), 7.82 (s, 1H, NCHCI), 7.55 – 7.48 (m, 2H, ArH), 7.39 – 7.35 (m, 2H, ArH), 
7.34 – 7.23 (m, 2H, ArH + CDCl3), 6.84 (d, J = 8.3 Hz, 1H, ArH), 4.02 (s, 3H, NCH3). 13C 
NMR (101 MHz, CDCl3) δ 166.8, 138.6, 137.6, 133.4, 133.3, 132.5, 130.5, 129.3, 125.2, 124.3, 
122.6, 119.9, 116.1, 110.7, 78.9, 33.9. IR ν 3107 (w), 3059 (w), 2948 (w), 1599 (s), 1552 (m), 
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1506 (m), 1454 (w), 1392 (m), 1277 (s), 1245 (s), 1225 (s), 1166 (s), 1131 (m), 1031 (s), 1004 
(w), 842 (w).  HR-ESI-MS calcd for C16H13INO2
+ [M+H]+ 377.9986, found 377.9990.  
1-(3-5-Iodo-1-methyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2b) 
Following procedure GP3: starting from 5-iodo-1-methyl-1H-indole 
34d (257 mg, 1.00 mmol), after 16 hours 1-(3-5-iodo-1-methyl-1H-
indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 2b (380 mg, 0.755 mmol, 76% 
yield) was obtained as a yellow amorphous solid. NB: the reagent is 
unstable in acidic deuterated solvents and it decompose in short time, 
we recommend the immediate use after the synthesis. The proton NMR presents about 21% 
of the open protonated form. Rf: 0.3 (DCM:MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.24 
(m, 1H, ArH), 7.83 (s, 1H, NCHCI), 7.58 – 7.47 (m, 2H, ArH), 7.26 (m, 1H, ArH + CDCl3 ), 
7.21 - 7.18 (m, 2H, ArH), 6.67 (d, J = 8.1 Hz, 1H, ArH), 3.87 (s, 3H, CH3N). 13C NMR (101 
MHz, CDCl3) δ 168.6, 140.5, 136.8, 133.7, 132.6, 132.3, 131.4, 130.3, 128.1, 126.0, 122.3, 
119.1, 115.7, 112.9, 86.1, 34.0. IR ν 3092 (w), 3061 (w), 1600 (s), 1584 (m), 1557 (m), 1503 
(m), 1436 (w), 1422 (w), 1371 (m), 1265 (s), 1245 (s), 1225 (m), 1163 (m), 1113 (w), 1031 (s), 
1004 (w), 836 (w).  HR-ESI-MS calcd for C16H12I2NO2
+ [M+H]+ 503.8952; found 503.8952.  
 
1-(3-1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole)-1H-1λ3 –benzo 
[b]iodo-3(2H)-one (2c) 
Following procedure GP3: starting from commercially available 1-
methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (149 
mg, 1.00 mmol), after 16 hours 1-(3-1-methyl-5-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 
2c (276 mg, 0.549 mmol, 54% yield) was obtained as an orange 
amorphous solid. Rf: 0.46 (DCM:MeOH 9:1). 1H NMR (400 MHz, CD2Cl2) δ 8.32 (dd, J = 
7.5, 1.7 Hz, 1H, ArH), 7.93 (s, 1H, NCHCI), 7.81 (dd, J = 8.4, 1.1 Hz, 1H, ArH), 7.74 (s, 1H, 
CCHCBPin), 7.59 – 7.48 (m, 2H, ArH), 7.31 (ddd, J = 8.6, 7.1, 1.7 Hz, 1H, ArH), 6.85 (dd, J 
= 8.3, 0.9 Hz, 1H, ArH), 3.99 (s, 3H, NCH3), 1.30 (s, 12H, CBPin). 13C NMR (101 MHz, 
CD2Cl2) δ 167.0, 140.1, 139.6, 134.1, 133.8, 132.6, 131.0, 130.5, 129.5, 127.6, 126.0, 117.1, 
110.7, 84.5, 80.3, 34.4, 25.2. NB: the Carbon-Boron bond is not observed as reported in 
literature.[18] IR ν 3095 (w), 2979 (w), 1611 (s), 1558 (w), 1507 (w), 1436 (w), 1360 (s), 1303 
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(w), 1263 (w), 1142 (s), 1114 (w), 1074 (w), 970 (w), 861 (w). HR-ESI-MS  calcd for 
C22H24BINO4
+ [M+H]+ 504.0838; found 504.0835.  
1-(3-1,2-Dimethyl-1H-indole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2d) 
Following procedure GP3: starting from 2-methyl-1-methyl-1H-indole 
34a (145 mg, 1.00 mmol), after 16 hours 1-(3-1,2-dimethyl-1H-indole)-
1H-1λ3 -benzo[b]iodo-3(2H)-one 2d (364 mg, 0.930 mmol, 93% yield) 
was obtained as a dark violet foam. Rf: 0.43 (DCM:MeOH 9:1).).  1H 
NMR (400 MHz, CDCl3) δ 8.42 (dd, J = 7.3, 1.7 Hz, 1H, ArH), 7.52 (td, 
J = 7.3, 0.9 Hz, 1H, ArH), 7.44 (d, J = 8.2 Hz, 1H, ArH), 7.35 (m, 2H, ArH), 7.28 (m, 1H, 
ArH), 7.23 (ddd, J = 8.2, 6.9, 1.0 Hz, 1H, ArH), 6.77 (m, 1H, ArH), 3.91 (s, 3H, CH3N), 2.65 
(s, 3H, ICH=CHCH3). 13C NMR (101 MHz, CDCl3) δ 166.8, 145.3, 137.9, 133.7, 133.2, 132.7, 
130.5, 128.9, 124.7, 123.6, 122.4, 119.2, 115.5, 110.4, 80.1, 31.1, 13.2. IR ν 3055 (w), 2987 
(w), 2948 (w), 1717 (w), 1605 (s), 1584 (m), 1553 (m), 1516 (w), 1472 (w), 1437 (w), 1395 
(m), 1378 (m), 1268 (m), 1154 (w), 1032 (w), 1011 (w), 829 (w). HR-ESI-MS calcd for 
C17H15INO2
+ [M+H]+ 392.0142; found 392.0146. 
1-(2-1-Methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2e) and 1-(3-1-methyl-1H-
pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2e’). 
Following procedure GP3: starting from 
commercially available 1-methyl-1H-pyrrole 
(0.890 ml, 1.00 mmol), after 12 hours 1-(2-1-
methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 2e and 1-(3-1-methyl-1H-pyrrole)-
1H-1λ3 -benzo[b]iodo-3(2H)-one 2e’ were obtained as a 1:1 mixture (310 mg, 0.948 mmol, 
overall yield 95%) as an off-white, sticky amorphous solid. Rf: 0.5 (DCM:MeOH 9:1). The two 
compounds were separated by slow flash column chromatography (EtOAc:MeOH 9:1).  
1-(2-1-methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 2e (152 mg, 
0.465 mmol, 47% yield; off-white, sticky amorphous solid) Rf: 0.3 
(EtOAc:MeOH 9:1). 1H NMR (400 MHz, CD3OD) δ 8.24 (dd, J = 7.5, 1.6 
Hz, 1H, ArH), 7.65 (td, J = 7.4, 1.0 Hz, 1H, ArH), 7.55 (m, 1H, ArH), 7.27 
(t, J = 2.1 Hz, 1H, ArH), 7.01 (dd, J = 3.9, 1.6 Hz, 1H, ArH), 6.72 (dd, J = 
8.3, 1.0 Hz, 1H, ArH), 6.43 (dd, J = 3.9, 2.1 Hz, 1H, ArH), 3.78 (s, 1H, NCH3). 13C NMR (101 
MHz, CD3OD) δ 170.1, 135.5, 134.2, 133.2, 131.9, 131.4, 127.7, 126.6, 119.4, 112.9, 96.0, 
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37.4. IR ν 3415 (w), 3105 (w), 3049 (w), 2950 (w), 1604 (s), 1584 (m), 1558 (w), 1508 (w), 
1437 (w), 1346 (m), 1288 (m), 1223 (w), 1149 (w), 1091 (w), 1047 (w), 1005 (w), 829 (m).  
HR-ESI-MS  calcd for C12H11INO2
+ [M+H]+ 327.9829; found 327.9842.  
1-(3-1-methyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 2e’ (158 
mg, 0.483 mmol, 48% yield; off-white, sticky amorphous solid). Rf: 
0.25 (EtOAc:MeOH 9:1). 1H NMR (400 MHz, CD3OD) δ 8.15 (dd, J 
= 7.5, 1.7 Hz, 1H, ArH), 7.53 (td, J = 7.3, 1.1 Hz, 1H, ArH), 7.49 – 7.40 
(m, 2H, ArH), 7.04 – 6.98 (m, 2H, ArH), 6.58 (d, J = 1.2 Hz, 1H, ArH), 
3.85 (s, 3H, NMe). 13C NMR (101 MHz, CD3OD) δ 170.0, 134.9, 134.2, 133.4, 132.8, 131.5, 
127.9, 127.7, 117.4, 116.6, 82.8, 37.1. IR ν 3447 (w), 3106 (w), 2947 (w), 2863 (w), 1603 (s), 
1591 (m), 1558 (m), 1512 (m), 1437 (w), 1354 (m), 1294 (w), 1110 (m), 1083 (w), 1007 (w), 
829 (m).  HR-ESI-MS calcd for C12H11INO2
+ [M+H]+ 327.9829; found 327.9842.  
1-(2-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2f) and 1-(3-1-benzyl-1H-
pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one (2f’) 
Following procedure GP3: starting from 
commercially available 1-benzyl-1H-pyrrole 
(0.890 ml, 1.00 mmol), after 12 hours 1-(2-1-
benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-
3(2H)-one 2f and 1-(3-1-benzyl-1H-pyrrole)-
1H-1λ3 -benzo[b]iodo-3(2H)-one 2f’ were 
obtained in 3:1 mixture (345 mg, 0.856 mmol, overall yield 86%), as a colorless amorphous 
solid. Rf: 0.7 (DCM:MeOH 9:1). The two compounds were separated by slow flash column 
chromatography (EtOAc:MeOH 9:1). 
 
1-(2-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 2f (85.0 mg, 
0.211 mmol, 21% yield); colorless foam. Rf: 0.5 (EtOAc:MeOH 9:1). 1H 
NMR (400 MHz, 2:1 mixture CD3OD:C6D6, referered to CD3OD) δ 8.18 
(dd, J = 7.5, 1.6 Hz, 1H, ArH), 7.28 (t, J = 7.4 Hz, 1H, ArH), 7.10 (t, J = 2.2 
Hz, 1H, ArH), 6.92 (m, J = 7.6, 2.9 Hz, 6H, ArH + C6D6), 6.71 (dd, J = 3.9, 
1.7 Hz, 1H, ArH), 6.35 (t, J = 3.4 Hz, 1H, ArH), 6.23 (d, J = 8.3 Hz, 1H, 
ArH), 4.90 (s, 2H, NCH2Ph). 13C NMR (101 MHz, 2:1 mixture CD3OD:C6D6, referered to 
CD3OD) δ 169.8, 136.9, 134.6, 132.7, 131.2, 131.1, 129.5, 129.0, 128.5, 127.2, 119.2, 112.9, 
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94.8, 54.7 (two Carbon signals under the deuterated benzene). IR ν 3109 (w), 3064 (w), 2968 
(w), 2875 (w), 1609 (s), 1585 (m), 1558 (w), 1503 (w), 1456 (w), 1440 (w), 1357 (m), 1277 
(w), 1103 (m), 1079 (w), 1032 (w), 1031 (w), 830 (w).  HR-ESI-MS calcd for 
C18H15INO2
+ [M+H]+ 404.0142; found 404.0140. 
 
1-(3-1-benzyl-1H-pyrrole)-1H-1λ3 -benzo[b]iodo-3(2H)-one 2f’ 
(260 mg, 0.645 mmol, 65% yield); colorless foam. Rf: 0.46 
(EtOAc:MeOH 9:1). 1H NMR (400 MHz, 2:1 mixture 
CD3OD:C6D6, refered to CD3OD) δ 8.29 (dd, J = 7.5, 1.7 Hz, 1H, 
ArH), 7.36 (t, J = 7.3 Hz, 1H, ArH), 7.30 – 7.20 (m, 3H ArH + C6D6), 7.18 – 7.08 (m, 3H, 
ArH), 6.97 (d, J = 2.0 Hz, 1H, ArH), 6.83 – 6.78 (m, 2H, ArH), 6.30 (dd, J = 3.0, 1.7 Hz, 1H, 
ArH), 4.93 (s, 2H, NCH2Ph). 13C NMR (101 MHz, 2:1 mixture CD3OD:C6D6, refered to 
CD3OD) δ 168.7, 136.8, 133.5, 133.0, 131.8, 130.9, 130.3, 128.8, 128.1, 127.4, 126.2, 125.5, 
116.3, 115.3, 82.4, 53.5. IR ν 3409 (w), 3114 (w), 2971 (w), 1609 (s), 1585 (m), 1558 (w), 
1456 (w), 1438 (w), 1365 (m), 1277 (s), 1160 (w), 1079 (w), 1032 (m), 835 (w).  HR-ESI-MS 
calcd for C18H15INO2
+ [M+H]+ 404.0142; found 404.0140. 
 
1-(3-1-Methyl-1H-indole)-3,3-dimethyl-1,3-dihydro-1λ3-benzo[d][1,2]iodoxole (3a) 
Following procedure GP3 (on 0.100 mmol scale): starting from 
commercially available 1-methyl-1-H-indole 5 (26.2 mg, 0.100 mmol) 
and 3,3-dimethyl-1λ3-benzo[d][1,2]iodoxol-1(3H)-yl acetate 12e 
(70.4 mg, 0.220 mmol, 1.10 equiv.), after 16 hours 1-(3-1-methyl-1H-
indole)-3,3-dimethyl-1,3-dihydro-1λ3-benzo[d][1,2]iodoxole 3a (40.1 
mg, 0.102 mmol, 51% yield) was obtained as a brown foam. Rf: 0.7 (DCM:MeOH 9:1). IR ν 
3115 (w), 3050 (w), 2986 (w), 1509 (w), 1455 (w), 1372 (w), 1284 (s), 1247 (s), 1225 (m), 
1166 (m), 1110 (w), 1031 (s), 992 (w).1H NMR (400 MHz, CDCl3) δ 7.92 (s, 1H, NCHCI), 
7.54 (m, 1H, ArH), 7.47 (m, 1H, ArH), 7.45 – 7.40 (m, 3H, ArH), 7.34 (ddd, J = 8.0, 6.9, 1.0 
Hz, 1H, ArH), 7.08 (ddd, J = 8.7, 5.8, 2.9 Hz, 1H, ArH), 6.87 (m, 1H, ArH), 4.02 (s, 3H, NCH3), 
1.75 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3) δ 146.3, 140.2, 137.7, 130.9, 130.4, 128.9, 
128.7, 127.0, 124.8, 123.3, 119.6, 111.0, 108.9, 74.6, 72.9, 34.2, 30.5. HR-ESI-MS calcd for 
C18H19INO
+ [M+H]+ 392.0506; found 392.0510.  
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1-(3-1-Methyl-1H-indole)-3,3-bis(trifluoromethyl)-1,3-dihydro-1λ3-
benzo[d][1,2]iodaoxole (4a) 
 Following procedure GP3 (on 0.100 mmol scale): starting from 
commercially available 1-methyl-1-H-indole 5 (26.2 mg, 0.100 
mmol), 1-acetoxy-1,3-dihydro-3,3-bis(trifluoromethyl)-1,2-
benziodoxole 12f (94.0 mg, 0.220 mmol, 1.10 equiv.) and in Et2O 
0.05 M, after 16 hours 1 (3-1-methyl-1H-indole)-3,3-
bis(trifluoromethyl)-1,3-dihydro-1λ3-benzo[d][1,2]iodaoxole 4a (56.1 mg, 0.112 mmol, 56% 
yield) was obtained as a brown foam. Rf: 0.7 (DCM:MeOH 9:1). IR ν 3069 (w), 2922 (w), 
2852 (w), 1732 (w), 1504 (m), 1457 (w), 1263 (s), 1212 (m), 1178 (s), 1157 (s), 1130 (m), 1047 
(w), 948 (s). 1H NMR (400 MHz, CDCl3) δ 7.86 (m, 1H, ArH), 7.53 (s, 1H, NCHCI), 7.52 – 
7.46 (m, 3H, ArH), 7.41 (ddd, J = 8.3, 7.0, 1.1 Hz, 1H, ArH), 7.28 (m, 1H, ArH), 7.23 (m, 1H, 
ArH), 6.95 (d, J = 8.3 Hz, 1H, ArH), 3.96 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3) δ 137.5, 
137.4, 131.7, 131.4, 130.1, 129.9, 126.9, 123.9, 123.2 (m), 122.1, 120.4, 112.2, 110.3, 84.2, 
81.55 (dt, J = 57.1, 28.5 Hz), 33.6 (one aromatic Carbon signal not resolved). HR-ESI-MS 
calcd for C18H13F6INO
+ [M+H]+ 499.9941; found 499.9946. 
General Procedure GP4 for the Synthesis of C2-IndoleBX Reagents 13a-13b. 
 
Note: prior to the reaction, the glassware requires to be carefully cleaned with aqua regia to 
remove all metal traces; the commercially available heterocyclic starting material were 
purified through a short plug of silica prior to being used. 
Following a reported procedure,[21] commercially available spray-dried KF (581 mg, 10.0 
mmol) was dried in a schlenk flask at 150 °C under vacuum over 5 min. After cooling down to 
r.t., 1-chloro-1,2-benziodoxol-(1H)-one 12d (1.00 equiv.) was added to the vial, followed by 
anhydrous MeCN (5 mL). The yellow slurry of 12a was stirred for 2 h at 80 °C. After cooling 
down to r.t., the suspension was filtered over a sintered glass filter in a dry schlenk flask under 
inert conditions (NB: oxygen has to be completely avoided). A solution of the correspondent 
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potassium trifluoroborate substrate 11a or 11f (2.00 mmol, in 15 mL MeCN, 1.00 equiv.) was 
added and the resulting solution stirred at r.t. The reaction was monitored in TLC (DCM:MeOH 
9:1). After 2 hours the solution slightly changed its color. The reaction was left running 
overnight, and stopped after 30 h. Then 5% aqueous NaBF4 (60 mL) was added and the reaction 
mixture was vigorously stirred for 1 additional hour. (The reaction was stopped upon 
completion checked by TLC). The quenched reaction mixture was extracted using DCM (2x40 
mL), the combined organic layers washed with saturated NaHCO3 solution (40 mL) and then 
the organic layer dried over Na2SO4. The solvent was then removed under reduced pressure and 
the crude product purified via column chromatography (DCM:MeOH 10:1) to afford pure 
reagents 13a-13b. 
1-(Tert-butyl 1H-indole-1-carboxylate)-1H-1λ3 -benzo[b]iodo-3(2H)-one (13a)  
Following general procedure GP4, starting from potassium trifluoro(1-
tert-butoxycarbonyl-1H-indol-2-yl)borate 11a  (646 mg, 2.00 mmol, in 
15 mL MeCN, 1.00 equiv.) and 1-chloro-1,2-benziodoxol-(1H)-one 
11a (565 mg, 2.00 mmol, 1.00 equiv.), 1-(tert-butyl 1H-indole-1-
carboxylate)-1H-1λ3 -benzo[b]iodo-3(2H)-one 13a (250 mg, 0.540 
mmol, 27%), was obtained as a brown solid. M.p. 150 °C, decomposition. Rf: 0.5 (DCM: 
MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.41 (dd, J = 7.6, 1.7 Hz, 1H, ArH), 8.31 (d, J = 
8.5 Hz, 1H, ArH), 7.74 – 7.59 (m, 2H, ArH), 7.55 – 7.42 (m, 3H, ArH), 7.37 (t, J = 7.6 Hz, 1H, 
ArH), 7.00 (d, J = 8.4 Hz, 1H, ArH), 1.44 (s, 9H, C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 
166.7, 148.5, 138.0, 134.0, 132.4, 130.9, 129.5, 127.5, 126.1, 126.0, 124.0, 121.7, 119.6, 116.1, 
105.9, 86.8, 27.8. (One aromatic carbon not resolved). IR ν 1728 (m), 1636 (s), 1567 (s), 1451 
(m), 1349 (m), 1227 (m), 1156 (w), 968 (w). HR-ESI-MS: calcd for C20H19INO4+ 464.0353 
[M + H]+; found 464.0353. 
1-(2-1-(Tosyl)-1H-indol-2-yl)-1H-1λ3 -benzo[b]iodo-3(2H)-one (13b)  
Following general procedure GP4, starting from potassium trifluoro(1-
(tosyl)-1H-indol-2-yl)borate  11f (943 mg, 2.50 mmol, 1.00 equiv.) and 
1-chloro-1,2-benziodoxol-(1H)-one xx (706 mg, 2.50 mmol, 1.00 
equiv.), 1-(2-1-(tosyl)-1H-indol-2-yl)-1H-1λ3 -benzo[b]iodo-3(2H)-
one 13b (205 mg, 0.400 mmol, 16% yield) was obtained as colorless 
solid. M.p.: 185 °C. Rf: 0.5 (DCM: MeOH 9:1). 1H NMR (400 MHz, Acetone-d6) δ 8.22 (d, J 
= 8.5 Hz, 1H, ArH), 8.08 (d, J = 7.4 Hz, 1H, ArH), 7.92 – 7.84 (m, 2H, ArH), 7.73 (s, 1H, ArH), 
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7.67 (d, J = 7.9 Hz, 1H, ArH), 7.54 (t, J = 7.3 Hz, 1H, ArH), 7.47 (ddd, J = 8.5, 7.2, 1.3 Hz, 
1H, ArH), 7.43 – 7.35 (m, 1H, ArH), 7.35 – 7.27 (m, 1H, ArH), 7.21 (d, J = 8.1 Hz, 2H, ArH), 
6.82 (d, J = 8.4 Hz, 1H, ArH), 2.20 (s, 3H, CH3). 13C NMR (101 MHz, Acetone-d6) δ 166.9, 
147.1, 138.6, 135.4, 134.9, 133.9, 132.2, 131.3, 131.2, 131.1, 128.2, 128.1, 127.9, 127.8, 125.1, 
123.1, 120.0, 115.6, 110.1, 21.4. IR ν 1646 (w), 1603 (s), 1558 (w), 1370 (m), 1173 (s), 1089 
(s), 1007 (w), 827 (w). HR-ESI-MS: calcd for C22H16INNaO4S
+ 539.9737 [M + Na]+; found 
539.9736. 
 
General Procedure GP5 for the Synthesis of C2-IndoleDBX Reagents 13c-13i. 
 
Note: prior to the reaction, the glassware requires to be carefully cleaned with aqua regia to 
remove all metal traces; the commercially available heterocyclic starting material were 
purified through a short plug of silica prior to being used. 
 
In a dry round bottom flask, commercially available 1-fluoro-3,3-dimethyl-1,2-benziodoxole 
12b (1.00 equiv.) was dissolved in anhydrous MeCN (0.050 M). Potassium trifluoro indole 
borate salt 11 (1.00 equiv.) was added, and the mixture was stirred at r.t under inert atmosphere. 
After 2 hour 5% aqueous NaBF4 (30 mL/mmol, 13.6 equiv.) was added and  the reaction 
mixture was additionally stirred for 1 hour. (The reaction was stopped upon completion, 
checked by TLC (DCM: MeOH 9:1). The quenched reaction mixture was extracted using DCM 
(2x20 mL), the combined organic layers were washed with saturated NaHCO3 solution (20 mL), 
then the organic layer was dried over Na2SO4. Then the solvent was removed under reduced 
pressure. Column chromatrography purification with EtOAc: MeOH (10:1) afforded the desired 
C2-IndoleDBXs 13c-13i. 
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1-(2-Tert-butyl 1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo[d][1,2]iodoxol  (13c) 
Following general procedure GP5, starting from potassium 
trifluoro(1-(tert-butoxycarbonyl-1H-indol-2-yl)borate 11a (168 mg, 
0.520 mmol, 1.00 equiv.) and commercially available 1-fluoro-3,3-
dimethyl-1,2-benziodoxole 12b (146 mg, 0.520 mmol, 1.00 equiv.), 
1-(2-tert-butyl 1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-
1λ3-benzo[d][1,2] iodoxol  13c was obtained (215 mg, 0.450 mmol, 86%) as an off-white foam 
(M.p.: 128-133 °C). [Using same procedure this reaction was scaled up upto 5.00 mmol scale 
(1.40 g of Indole salt 11a)  and desired product 13c was obtained (2.02 g, 4.23 mmol, 85% 
yield) in same efficiency]. Rf: 0.6 (DCM: MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.34 (dd, 
J = 8.5, 1.0 Hz, 1H, ArH), 7.59 (dt, J = 7.8, 1.1 Hz, 1H, ArH), 7.46 (td, J = 7.3, 1.0 Hz, 1H, 
ArH), 7.43 – 7.36 (m, 2H, ArH), 7.32 – 7.26 (m, 1H, ArH), 7.20 – 7.16 (m, 1H, ArH), 7.15 (d, 
J = 0.8 Hz, 1H, ArH), 6.84 (dd, J = 8.3, 1.0 Hz, 1H, ArH), 1.54 (s, 6H, C(CH3)2), 1.46 (s, 9H, 
C(CH3)3).13C NMR (101 MHz, CDCl3) δ 149.3, 148.3, 137.7, 130.1, 129.9, 128.7, 127.0, 126.8, 
125.7, 123.1, 122.3, 120.9, 119.3, 115.8, 113.9, 85.0, 74.8, 32.3, 27.8. IR ν  2968 (w), 1729 (s), 
1435 (m), 1354 (s), 1325 (s), 1159 (s), 1136 (m), 1032 (m), 970 (m), 801 (m), 746 (s). HR-
ESI-MS: calcd for C22H25INO3
+ 478.0874 [M + H]+; found 478.0886. 
1-(2-1-Tosyl-1H-indole)-3,3-dimethyl-1,3-dihydro-1λ3-benzo[d][1,2] iodoxole (13d) 
Following general procedure GP5, starting from potassium 
trifluoro(1-(tosyl)-1H-indol-2-yl)borate  11f (566 mg, 1.50 mmol, 
1.00 equiv.) and commercially available 1-fluoro-3,3-dimethyl-1,2-
benziodoxole 12b (420 mg, 1.5 mmol, 1.00 equiv.), 1-(2-1-tosyl-1H-
indole)-3,3-dimethyl-1,3-dihydro-1λ3-benzo[d][1,2] iodoxole 13d 
(425 mg, 0.800 mmol, 53% yield) was obtained as colorless solid. M.p. 135-138 °C. Rf: 0.4 
(DCM: MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.31 (dd, J = 8.5, 1.0 Hz, 1H, ArH), 7.81 – 
7.74 (m, 2H, ArH), 7.56 (dt, J = 7.8, 1.1 Hz, 1H, ArH), 7.47 – 7.32 (m, 3H, ArH), 7.30 (td, J = 
7.6, 1.0 Hz, 1H, ArH), 7.18 – 7.11 (m, 3H, ArH), 7.07 (ddd, J = 8.4, 6.8, 1.7 Hz, 1H), 6.69 (dd, 
J = 8.3, 0.9 Hz, 1H, ArH), 2.31 (s, 3H, CH3), 1.58 (s, 6H, C(CH3)2).13C NMR (101 MHz, 
CDCl3) δ 148.3, 145.2, 137.6, 135.5, 130.6, 129.9, 129.8, 128.9, 127.1, 126.7, 126.4, 126.1, 
123.7, 123.6, 121.4, 120.2, 114.7, 114.4, 75.2, 31.5, 21.5. IR ν 2963 (w), 1597 (w), 1562 (w), 
1430 (m), 1366 (s), 1155 (s), 1090 (s), 951 (m). HR-ESI-MS: calcd for C24H23INO3S
+ 532.0438 
[M + H]+; found 532.0436. 
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1-(2-5-Methoxy-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo [d][1,2]iodoxole (13e) 
 Following general procedure GP5, starting from potassium 
trifluoro(1-(tert-butoxycarbonyl)-5-methoxy-1H-indol-2-
yl)borate 11b (706 mg, 2.00 mmol, 1.00 equiv.) and 
commercially available 1-fluoro-3,3-dimethyl-1,2-
benziodoxole 12b (560 mg, 2.00 mmol, 1.00 equiv.), 1-(2-5-
methoxy-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-benzo 
[d][1,2]iodoxole 13e (775 mg, 1.53 mmol, 76% yield) was obtained as brown solid foam. M.p. 
72-75 °C. Rf: 0.5 (DCM: MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.18 – 8.06 (m, 1H, ArH), 
7.40 – 7.36 (m, 1H, ArH),  7.30 (dd, J = 7.6, 1.6 Hz, 1H, ArH), 7.10 (ddd, J = 8.4, 7.0, 1.6 Hz, 
1H, ArH), 7.01 (s, 1H, ArH), 6.95 (dq, J = 5.9, 2.6 Hz, 2H, ArH), 6.76 (dd, J = 8.3, 1.0 Hz, 1H, 
ArH), 3.79 (s, 3H, OCH3), 1.46 (s, 6H, C(CH3)2), 1.36 (s, 9H, C(CH3)3). 13C NMR (101 MHz, 
CDCl3) δ 156.1, 149.3, 148.4, 132.5, 130.9, 130.0, 128.9, 127.2, 126.9, 122.3, 119.1, 116.6, 
115.1, 114.0, 102.7, 85.0, 74.8, 55.6, 32.4, 27.9. IR ν 2965 (w), 1727 (s), 1612 (w), 1434 (w), 
1357 (m), 1325 (s), 1253 (m), 1159 (s), 1117 (s), 1026 (s), 844 (m), 756 (s). HR-ESI-MS: calcd 
for C23H27INO4
+ 508.0979 [M + H]+; found 508.0981. 
1-(2-6-Methoxy-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo [d][1,2]iodoxole (13f) 
Following general procedure GP5, starting from potassium 
trifluoro(1-(tert-butoxycarbonyl)-6-methoxy-1H-indol-2-
yl)borate 11c (706 mg, 2.00 mmol, 1.00 equiv.) and 
commercially available 1-fluoro-3,3-dimethyl-1,2-
benziodoxole 12b (560 mg, 2.00 mmol, 1.00 equiv.), the 
corresponding indole reagent 13f (812 mg, 1.60 mmol, 80% yield) was obtained as brown solid 
foam, (M.P.: 70-75 °C). Rf: 0.6 (DCM: MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J 
= 2.3 Hz, 1H, ArH), 7.41 (d, J = 8.2 Hz, 2H, ArH), 7.34 (dd, J = 7.6, 1.6 Hz, 1H, ArH), 7.14 
(ddd, J = 8.4, 6.9, 1.5 Hz, 1H, ArH), 7.05 (s, 1H, ArH), 6.90 (dd, J = 8.6, 2.3 Hz, 1H, ArH), 
6.85 – 6.80 (m, 1H, ArH), 3.88 (s, 3H, OCH3), 1.50 (s, 6H, C(CH3)2), 1.41 (s, 9H, C(CH3)3).13C 
NMR (101 MHz, CDCl3) δ 158.8, 149.4, 148.3, 138.8, 129.8, 128.7, 126.9, 126.8, 123.8, 122.6, 
121.3, 117.1, 114.1, 113.0, 99.4, 84.9, 74.7, 55.5, 32.4, 27.8. IR ν 2963 (w), 1727 (m), 1613 
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(w), 1487 (w), 1362 (m), 1326 (s), 1155 (s), 1045 (m), 945 (m), 824 (m), 756 (m). HR-ESI-
MS: calcd for C23H27INO4
+ 508.0979 [M + H]+; found 508.0983. 
1-(2-5-Bromo-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-benzo 
[d][1,2]iodoxole (13g) 
Following general procedure GP5, starting from potassium 
trifluoro(1-(tert-butoxycarbonyl)-6-bromo-1H-indol-2-yl)borate 
11d (402 mg, 1.00 mmol, 1.00 equiv.) and commercially 
available 1-fluoro-3,3-dimethyl-1,2-benziodoxole 12b (280 mg, 
1.00 mmol, 1.00 equiv.), 1-(2-5-bromo-1-tert-butyl-1H-indole-1-
carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-benzo [d][1,2]iodoxole 13g (377 mg, 0.680 mmol, 
68% yield) was obtained as off-white solid foam. M.p. 73-78 °C Rf: 0.5 (DCM: MeOH 9:1). 
1H NMR (400 MHz, CDCl3) δ 8.54 (dt, J = 1.5, 0.7 Hz, 1H, ArH), 7.50 – 7.35 (m, 4H, ArH), 
7.18 (ddd, J = 8.4, 7.0, 1.6 Hz, 1H, ArH), 7.13 (d, J = 0.8 Hz, 1H, ArH), 6.80 (dd, J = 8.3, 1.0 
Hz, 1H, ArH), 1.54 (s, 6H, C(CH3)2), 1.45 (s, 9H, C(CH3)3).13C NMR (101 MHz, CDCl3) δ 
149.1, 148.3, 138.3, 130.1, 129.1, 129.0, 127.2, 127.1, 126.6, 122.3, 121.9, 120.0, 119.1, 114.0, 
85.9, 75.1, 32.2, 27.8 (one C is not resolved). IR ν 2969 (w), 1731 (s), 1352 (s), 1321 (s), 1235 
(m), 1157 (s), 1137 (m), 1031 (m), 970 (m), 908 (m), 754 (s). HR-ESI-MS: calcd for 
C22H24
79BrINO3
+ 555.9979 [M + H]+; found 556.0001 
 
1-(2-3-Methyl-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-benzo 
[d][1,2]iodoxole (13h) 
Following general procedure GP5, starting from potassium 
trifluoro(1-(tert-butoxycarbonyl)-3-methyl-1H-indol-2-yl)borate 
11e (1.69 g, 5.00 mmol, 1.00 equiv.) and commercially available 1-
fluoro-3,3-dimethyl-1,2-benziodoxole 12b (1.41 mg, 5.00 mmol, 
1.00 equiv.), 1-(2-3-methyl-1-tert-butyl-1H-indole-1-carboxylate)-
3,3-dimethyl-1,3-dihydro-1λ3-benzo [d][1,2]iodoxole 13h (2.40 g, 
4.88 mmol, 97% yield) was obtained as off-white foam. M.p. 128-130 °C. Rf: 0.6 (DCM: 
MeOH 9:1). 1H NMR (400 MHz, CDCl3) δ 8.27 (d, J = 8.4 Hz, 1H, ArH), 7.53 (d, J = 7.8 Hz, 
1H, ArH), 7.46 – 7.32 (m, 3H, ArH), 7.28 (t, J = 7.5 Hz, 1H, ArH), 7.12 (t, J = 7.6 Hz, 1H, 
ArH), 6.80 (d, J = 8.3 Hz, 1H, ArH), 2.42 (s, 3H, CH3), 1.54 (s, 6H, C(CH3)2), 1.45 (s, 9H, 
C(CH3)3). 13C NMR (101 MHz, CDCl3) δ 149.3, 148.4, 137.5, 129.7, 129.6, 128.6, 126.8, 
126.4, 125.8, 122.7, 119.3, 117.6, 115.8, 113.3, 84.5, 74.3, 32.3, 27.7, 11.9 (one aromatic 
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carbon signal is not resolved)  IR ν 1727 (w), 1352 (w), 1325 (m), 1157 (s), 1089 (m), 971 (w), 
857 (w), 750 (s). HR-ESI-MS: calcd for C23H27INO3
+ 492.1030 [M + H]+; found 492.1038. 
 
1-(2-(1H-Indol-3-yl)ethyl)isoindoline-1,3-dione)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo[d][1,2] iodoxole (13i) 
Following general procedure GP5, starting from potassium 
trifluoro(2-(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione) borate  
11g (396 mg, 1.00 mmol, 1.00 equiv.) and commercially available 
1-fluoro-3,3-dimethyl-1,2-benziodoxole (280 mg, 1.00 mmol, 1.00 
equiv.), 1-(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione)-3,3-
dimethyl-1,3-dihydro-1λ3-benzo[d][1,2] iodoxole 13i (347 mg, 0.630 mmol, 63% yield) was 
obtained as yellow solid. M.p. 132-135 °C. Rf: 0.4 (DCM: MeOH 9:1). 1H NMR (400 MHz, 
CDCl3) δ 7.73 – 7.58 (m, 5H, ArH), 7.48 (d, J = 8.4 Hz, 1H, ArH), 7.22 (d, J = 7.5 Hz, 3H, 
ArH), 7.07 (t, J = 7.5 Hz, 1H, ArH), 6.96 – 6.84 (m, 1H, ArH), 6.66 (d, J = 8.3 Hz, 1H, ArH), 
3.83 (t, J = 7.7 Hz, 2H, NCH2), 3.12 (bs, 2H, C-CH2), 1.57 (s, 6H, C(CH3)2). (NH was not 
resolved). 13C NMR (101 MHz, CDCl3) δ 167.9, 148.1, 139.5, 133.7, 131.9, 130.0, 129.3, 
127.4, 126.9, 126.5, 123.8, 123.0, 121.0, 119.9, 119.1, 112.6, 112.4, 73.8, 38.5, 29.7, 25.6 (one 
aromatic Carbon signal is not resolved). IR ν 2965 (w), 1704 (m), 1434 (m), 1356 (w), 1155 
(s), 954 (s), 871 (m), 748 (s).  HR-ESI-MS: calcd for C27H24IN2O3
+ 551.0826 [M + H]+; found 
551.0834. 
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3. Metal Free (Hetero)-Arylation of Indoles.  
All commercially available chemicals were purchased from the suppliers quoted in Paragraph 
1.0 of Supplementary Informations: these chemicals were purified through a short plug of celite 
prior to their use in catalysis. The synthesis of non commercial available compounds is 
presented below. 
The synthesis of the starting materials 34a-34f  had been already described before.[1] The 
procedures here reported are taken from the cited publication to facilitate reproduction of the 
results by having all the data in the same file. 
 
3.1 Synthesis of Methylated Indoles.  
 
General Procedure GP6 for the N-Methylation of Indoles. 
 
GP6: The corresponding indole (1.00 - 5.00 mmol, 1.00 equiv.) was dissolved in dry THF (0.3 
M). Sodium hydride (60% suspension in mineral oil; 1.50 equiv.) was slowly added under N2 
flow at 0 °C. After being stirred at 0 °C for 15 min,the reaction mixture was allowed to warm 
to r.t for 1.5 h. It was then cooled back to 0 °C and methyl iodide (1.30 equiv.) was added. The 
mixture was warmed to r.t. and stirred overnight. After cooling again to 0 °C, the reaction was 
quenched with water (10 mL), extracted with Et2O (3 x 10 mL), the combined organic layers 
were dried over MgSO4, and the solvent removed under reduced pressure. The resulting crude 
product was purified via flash column chromatography (Pentane:EtOAc 9:1-4:1), to give the 
desired N-methylated indole. 
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Figure 3.1 Methylated Indole used for IndoleBX’s synthesis and Nucleophilic partners 
 
1,2-Dimethyl-1H-indole (34a) 
Following procedure GP6: starting from commercially available 2-
methylindole  (656 mg, 5.00 mmol), 1,2-dimethyl-1H-indole 34a (683 mg, 
4.70 mmol, 94% yield) was obtained as an off-white solid. 1H NMR (400 
MHz CDCl3) δ 7.69 (d, J = 7.8 Hz, 1H, ArH), 7.41 (dd, J = 8.1, 1.0 Hz, ArH), 
7.32 (m, 1H, ArH), 7.24 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 6.42 (s, 1H, NC(CH3)CH), 3.79 
(s, 3H, NCH3), 2.57 (d, J = 1.0 Hz, 3H, NCCH3). 13C NMR (125 MHz, CDCl3) δ  138.1, 136.9, 
128.1, 120.6, 119.8, 119.4, 108.8, 99.7, 29.5, 12.9. IR ν (neat) 3050 (w), 3020 (w), 2970 (m), 
1610 (w), 1400 (s), 1340 (m), 1240 (m), 930 (m), 910 (w), 780 (m), 750 (m), 730 (s).  1H NMR 
values are in accordance with the data reported in literature.[22] 
 
5-Methoxy-1-methyl-1H-indole (34b) 
Following procedure GP6: starting from commercially available 5-
methoxy-1H-indole (736 mg, 5.00 mmol), 5-methoxy-1-methyl-1H-indole 
34b (730 mg, 4.53 mmol, 91% yield) was obtained as a colorless crystalline 
solid. 1H NMR (400 MHz, CDCl3) δ 7.30 (d, 1H, J = 8.5 Hz, ArH) 7.13 (s, 
1H, ArH), 7.05 (s, 1 H, ArH), 6.92 (d, 1H, J = 8.8 Hz, ArH), 6.43 (d, 1H, J = 1.0 Hz, ArH), 
3.90 (s, 3H, NMe), 3.80 (s, 3H, OMe). 13C NMR (101 MHz, CDCl3) δ 154.0, 132.2, 129.3, 
128.8, 111.9, 109.9, 102.5, 100.4, 55.9, 33.0. IR ν 2952 (w), 2918 (w), 2834 (w), 1622 (m), 
1608 (w), 1577 (w), 1496 (s), 1459 (w), 1450 (m), 1449 (m), 1421 (s), 1347 (w), 1293 (w), 
1243 (s), 1191 (m), 1152 (s), 1102 (w), 1026 (m), 942 (w), 855 (m), 845 (w), 805 (s). 
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5-Chloro-1-methyl-1H-indole (34c) 
Following procedure GP6: starting from commercially available 5-chloro-
1H-indole (758 mg, 5.00 mmol), 5-chloro-1-methyl-1H-indole 34c (800 mg, 
4.83 mmol, 97% yield) was obtained as a colorless solid. 1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, J = 2.1 Hz, 1H, ArH), 7.30 – 7.19 (m, 2H, ArH), 7.10 (d, J 
= 3.1 Hz, 1H, ArH), 6.47 (dd, J = 3.1, 0.7 Hz, 1H, ArH), 3.80 (s, 3H, NCH3). 13C NMR (101 
MHz, CDCl3) δ 135.1, 130.1, 130.1, 125.1, 121.8, 120.2, 110.2, 100.6, 33.1. IR ν 3102 (w), 
2943 (w), 2913 (w), 2881 (w), 2817 (w), 1567 (w), 1513 (m), 1475 (s), 1441 (m), 1421 (s), 
1379 (w), 1331 (m), 1278 (s), 1241 (s), 1199 (m), 1146 (m), 1106 (w), 1082 (m), 1063 (s), 1009 
(m), 909 (m), 870 (m), 869 (m). 
 
5-Iodo-1H-indole (34d) 
Following procedure GP6: starting from commercially available 5-iodo-1H-
indole (257 mg, 1.00 mmol), 5-iodo-1-methyl-1H-indole 34d (380 mg, 0.755 
mmol, 76% yield) was obtained as a colorless solid. 1H NMR (400 MHz, 
CDCl3) δ 7.98 (s, 1 H, ArH), 7.49 (d, J = 8.6 Hz, 1H, ArH), 7.13 (d, J = 8.6 
Hz, 1H, ArH), 7.04 (s, 1H, ArH), 6.43 (s, 1H, ArH), 3.80 (s, 3H, NCH3). 13C NMR (101 MHz, 
CDCl3) δ 135.8, 131.0, 129.8, 129.7, 129.6, 111.3, 100.3, 82.9, 33.0.  IR ν 3093 (w), 3053 (w), 
2940 (w), 2919 (w), 2886 (w), 2876 (w), 2856 (w), 1557 (m), 1510 (s), 1473 (s), 1432 (m), 
1420 (s), 1379 (w), 1329 (m), 1277 (s), 1242 (s), 1193 (w), 1151 (w), 1103 (m), 1079 (m), 1045 
(w), 1007 (m), 888 (s), 868 (m). 
 
6-(Benzyloxy)-1-methyl-1H-indole (34e) 
Following procedure GP6: starting from commercially available 6-
benzyloxyindole (223 mg, 1.00 mmol), 6-(benzyloxy)-1-methyl-1H-indole 
34e (237 mg, 1.00 mmol, 100% yield) was obtained as a orange solid. 1H 
NMR (400 MHz, CDCl3) δ 7.53 – 7.48 (m, 3H, ArH), 7.43 – 7.38 (m, 2H, 
ArH), 7.34 (m, 1H, ArH), 6.96 (d, J = 3.1 Hz, 1H, ArH), 6.93 – 6.85 (m, 2H, ArH), 6.43 (dd, J 
= 3.1, 0.8 Hz, 1H, ArH), 5.15 (s, 2H, CH2), 3.73 (s, 3H, NMe). 
1H-NMR values are in 
accordance with the data reported in literature.[23] 
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3.2 Optimization of the Metal Free (Hetero)-Arylation of Indoles with the C3 Reagent.  
 
Table 3.1: equivalents of 1 and LA screening: 
 
Entry Equiv. of xx Lewis Acid (equiv.) Yield%a xx/xx 
1 1.5 TMSBr (2) 41.4%/17% 
2 1 - -b 
3 1 TMSBr (2) 40%/23% 
4 1 TMSBr (1) 44%/12% 
5 1 TMSCl (1) 68%/- 
6 1 TMSI (1) -c 
a) Substrate 2a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (equiv. given in the table), TMSCl-TMSBr-
TMSI (x equiv.) and HFIP (0.1 M) at 25 °C. Isolated yield after flash chromatography is given. b) 
no conversion, reagent 2a and nucleophile 1 are recovered. c) complete decomposition and 
polymerization. 
Table 3.2: Screening of the solvent: 
 
Entry Solvent  Yield%a xx/xx 
1 DCM  -b 
2 DCE  -b 
3 MeCN  4%/- 
4 THF  -b 
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5 Et2O  traces/- 
6 HFIP  68%/- 
7 MeOH  traces/- 
8 TFE  20%/- 
a) Substrate 2a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 
mmol), TMSCl (1.00 equiv.) and HFIP (0.1 M) at 25 °C. Isolated yield 
after flash chromatography is given. b) no conversion, reagent xx and 
nucleophile xx are recovered.  
Table 3.3: screening of TMSCl equivalents: 
 
Entry TMSCl (equiv.) Yield%a xx/xx 
1 0.1 -b 
2 0.2 -b 
3 0.4  4%/- 
4 0.5 10%/- 
5 0.8 39%/- 
6 1  68%/- 
7 1.2 70%/- 
8 2 40%/-c 
a) Substrate 2a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 
mmol), TMSCl (X equiv.) and HFIP (0.1 M) at 25 °C. Isolated yield 
after flash chromatography is given. b) no conversion, reagent 2a and 
nucleophile 1 are recovered. c) decomposition and polymerization of 
both reagent 2a and nucleophile 1 are detected. 
 
Table 3.4: Screening of substrate’s molarity in HFIP: 
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Entry HFIP (M) Yield%a xx/xx 
1 0.012 44%/-b 
2 0.025 47%/-b 
3 0.1 68%/- 
4 0.25 64%/-c 
5 0.5 = 20 equiv. 70%/-c 
a) Substrate 2a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 
mmol), TMSCl (1.00 equiv.) and HFIP (X M) at 25 °C. Isolated yield 
after flash chromatography is given. b) reagent 2a and nucleophile 1 
are recovered. c) solubility problem of reagent 2a, incomplete reaction. 
 
Table 3.5: Screening of HFIP equivalents and concentration in DCM: 
 
Entry DCM (M) HFIP (equiv.) Yield%a xx/xx 
1 0.1 20 equiv. = 0.5 M 75%/- 
2 0.1 10  68%/- 
3 0.1 5 64%/- 
4 0.1 2 -b 
5 0.1 1 -b 
6 0.2 5 66%/- 
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7 0.2 10 75%/- 
8 0.2 20 75%/- 
9 0.25 10 68%/-c 
a) Substrate 2a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 mmol), TMSCl (1.00 equiv.) and HFIP (X 
equiv.) in DCM (X M) at 25 °C. Isolated yield after flash chromatography is given. b) no conversion, 
reagent 2a and nucleophile 1 are recovered. c) decomposition of the reagent 2a is detected 
Table 3.6: screening of HFIP equivalents and concentration in DCM at 50 °C: 
 
Entry T (°C) HFIP (equiv.) DCM (M) Yield%a xx/xx 
1 25 10  0.2 75%/- 
2 50 10  0.1 74%/-b 
3 50 5 0.1 70%/- b 
4 50 2 0.1 68%/- b 
5 50 1 0.1 23%/- b 
a) Substrate 2a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 mmol), TMSCl (1.00 equiv.) and HFIP (X 
equiv.) in DCM (X M) at 25 °C. Isolated yield after flash chromatography is given. b) decomposition of the 
reagent 2a is detected 
 
Substrate 3a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 mmol), TMSCl (1.00 equiv.) in HFIP (0.1 M) at 25 
°C. Isolated yield after flash chromatography is given.  
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Substrate 4a (0.100 mmol), 1,3,5 trimethoxybenzene 1 (0.100 mmol), TMSCl (1.00 equiv.) in HFIP (0.1 M) at 25 
°C. Isolated yield after flash chromatography is given.  
Table 3.7: Optimization for Lewis acid and solvents for Arylation of IndoleDBX 
 
Entrya Lewis Acid (equiv.) Solvent Yield%a  
1 TMSCl (2) HFIP (0.1 M) -b 
2 TMSCl (2) HFIP (10.0 equiv.)+DCM(0.2 M) Traces 
3 TMSBr (2) HFIP 60% 
4 TMSBr (1) HFIP (10.0 equiv.)+DCM(0.2 M) 77% 
5 TMSI (2) HFIP (10.0 equiv.)+DCM(0.2 M) -c 
6 TMS-1H-imidazole (2) HFIP (10.0 equiv.)+DCM(0.2 M) -c 
a) Substrate 13c (0.100 mmol), 1,3,5 trimethoxybenzene 1 (xx 0.110mmol, 1.10 equiv.), TMSCl-TMSBr-
TMSI (2 equiv.) at 25 °C. Isolated yield after flash chromatography is given. b) no conversion, reagent 
13c and nucleophile 1 are recovered. c) complete decomposition and polymerization. 
 
1-Methyl-2,3-bis(2,4,6-trimethoxyphenyl)-1H-indole (8). 
S38 
 
White resin. Rf: 0.38 (Pentane:EtOAc 1:1) 1H NMR (400 MHz, 
CDCl3) δ 7.37 – 7.28 (m, 2H, ArH), 7.13 (ddd, J = 8.3, 7.0, 1.1 Hz, 
1H, ArH), 6.99 (ddd, J = 7.9, 7.0, 0.9 Hz, 1H, ArH), 6.12 (s, 2H, ArH), 
6.11 (s, 2H, ArH), 3.82 (s, 3H, OMe), 3.82 (s, 3H, OMe), 3.60 (s, 3H, 
OMe), 3.57 (s, 6H, NMe), 3.53 (s, 6H, OMe). 13C NMR (101 MHz, 
CDCl3) δ 161.3, 159.8, 159.5, 159.2, 137.1, 131.8, 127.8, 120.6, 120.3, 
118.4, 109.3, 107.2, 106.7, 103.8, 90.5, 90.4, 55.5, 55.5, 55.2, 55.2, 30.7. IR ν 3001 (w), 2935 
(w), 2836 (w), 1587 (m), 1584 (s), 1464 (m), 1415 (m), 1336 (w), 1226 (s), 1128 (s), 1041 (w), 
811 (m), 741 (m). HR-ESI-MS calcd for C27H29NO6
+ [M+H]+ 464.1995; found 464.2093. 
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3.3 Control experiments  
 
 
 
In an open air vial, commercially available 3-Iodoindole 6 (26.0 mg, 0.100 mmol, 1.00 equiv.), 
1,3,5-trimethoxybenzene 1 (25.0 mg, 0.150 mmol, 1.50 equiv.) and TMSBr (26.0 µL, 0.200 
mmol, 2.00 equiv.) were dissolved in HFIP (1 mL, 0.1 M). The reaction was stirred for three 
hours and then quenched with sat. aqueous NaHCO3 (4 mL); the organic layer was extracted 
with DCM (3x5 mL), then the solvent was removed under reduced pressure. No conversion in 
the desired product 1-methyl-3-(2,4,6-trimethoxyphenyl)-1H-indole 7a was detected. 
 
 
 
 
In an open air vial, IndoleBX reagent 2a (38.0 mg, 0.100 mmol, 1.00 equiv.), 1,3,5-
trimethoxybenzene 1 (25.0 mg, 0.150 mmol, 1.50 equiv.) and HCl in EtOH (80.0 µL, 0.200 
mmol, 2.00 equiv., 1.25 M in EtOH) were dissolved in HFIP (1 mL, 0.1 M). The reaction was 
stirred for three hours and then quenched with sat. aqueous NaHCO3 (20 mL); the organic layer 
was extracted with DCM (3x5 mL), then the solvent was removed under reduced pressure. No 
conversion in the desired product 1-methyl-3-(2,4,6-trimethoxyphenyl)-1H-indole 7a was 
detected. 
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In an open air vial, commercially available N-methylindole 5 (13 µL, 0.10 mmol, 1.00 equiv.) 
and commercially available 4F-PIDA (34.0 mg, 1.00 mmol, 1.00 equiv) were left stirring in 
HFIP (1 mL, 0.1 M) for 30 minutes. Then 1,3,5-trimethoxybenzene 1 (25.0 mg, 0.150 mmol, 
1.50 equiv.) and TMSCl (25.5 µL, 0.200 mmol, 2.00 equiv.) were added to the mixture. The 
reaction mixture was stirred for three hours and then quenched with sat. aqueous NaHCO3 (4 
mL); the organic layer was extracted with DCM (3x5 mL), then the solvent was removed under 
reduced pressure. 1-methyl-3-(2,4,6-trimethoxyphenyl)-1H-indole 7a was obtained as white 
resin (4.80 mg, 16.0 µmol, 16% yield). For full characterization see the scope section. 
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3.4 Scope of the Metal Free (Hetero)-Arylation of Indoles.  
General Procedures GP7-GP9 Metal Free (Hetero)-Arylation of Indoles. 
 
GP7: In an open air vial, the corresponding IndoleBX 2a-2f’ (0.300 mmol, 1.00 equiv.), the 
1,3,5-trimethoxybenzene 1 (0.300 mmol, 1.00 equiv.), HFIP (315 µL, 3.00 mmol, 10.0 equiv.) 
and TMSCl (38.0 µL, 0.300 mmol, 1.00 equiv.) were dissolved in DCM (1.50 mL, 0.2 M). The 
reaction was stirred for three hours and then quenched with sat. aqueous NaHCO3 (4 mL); the 
organic layer was extracted with DCM (3x5 mL), then the solvent was removed under reduced 
pressure. Flash column chromatography (Pentane:EtOAc 9:1) afforded the desired products 7a-
7f. 
 
 
GP8: In an open air vial, IndoleBX 2a-2f’ (0.300 mmol, 1.00 equiv.), the corresponding 
heterocycle (0.300 mmol, 1.00 equiv.), HFIP (315 µL, 3.00 mmol, 10.0 equiv.) and TMSCl 
(38.0 µL, 0.300 mmol, 1.00 equiv.) were dissolved in DCM (1.50 mL, 0.2 M). The reaction was 
stirred for three hours and then quenched with sat. aqueous NaHCO3 (4 mL); the organic layer 
was extracted with DCM (3x5 mL), then the solvent was removed under reduced pressure. 
Flash column chromatography (Pentane:DCM 1:1) afforded the desired products 8a-10b. 
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GP9: In an open air vial, the corresponding C2-IndoleDBXs or C2-IndoleBXs 13a-13i (0.20 
mmol, 1.0 equiv.), the 1,3,5-trimethoxybenzene (1) or the heterocycle (0.22 mmol, 1.1 equiv.), 
HFIP (210 µL, 2.00 mmol, 10.0 equiv.) and TMSBr (52.8 µL, 0.400 mmol, 2.00 equiv.) were 
dissolved in DCM (1.0 mL, 0.20 M). The reaction was stirred for three hours and then quenched 
with saturated aqueous NaHCO3 (4 mL); the organic layer was extracted with DCM (3x5 mL), 
then the solvent was removed under reduced pressure. Purification on Preparative TLC (with 
mixture of EtOAc and Pentane as eluent) afforded the desired products 14a-16. 
 
3.4.1: Scope of trimethoxyphenylated-N-protected-Indoles and -Pyrroles 
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1-Methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole (7a) 
Following procedure GP7: using IndoleBX reagent 2a (113 mg, 0.300 
mmol), after 3 hours 1-methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole 
7a (64.0 mg, 0.216 mmol, 75% yield) was obtained as a white resin. 
Rf: 0.42 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 7.62 
(d, J = 7.8 Hz, 1H, ArH), 7.33 (d, J = 8.2 Hz, 1H, ArH), 7.18 (ddd, J 
= 8.1, 7.0, 1.2 Hz, 1H, ArH), 7.08 (m, 1H, ArH), 6.45 (s, 1H, ArH), 6.24 (s, 2H, ArH), 3.89 (s, 
3H, OMe), 3.73 (s, 6H, OMe), 3.51 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) δ 161.9, 160.0, 
137.1, 133.2, 128.0, 120.5, 120.4, 118.9, 109.2, 103.0, 102.4, 90.7, 55.8, 55.4, 30.1. IR ν 2379 
(w), 2321 (w), 1627 (s), 1523 (m), 1438 (s), 1362 (m), 1287 (m), 1178 (w), 1106 (s), 1073 (s), 
979 (w), 906 (m), 850 (m), 720 (s). HR-ESI-MS calcd for C18H20NO3
+ [M+H]+ 298.1438; 
found 298.1451. 
 
5-Iodo-1-methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole (7b) and and 5-iodo-1-methyl-
2,3-bis(2,4,6-trimethoxyphenyl)-1H-indole (7b’) 
Following procedure GP7: using IndoleBX 
reagent 2c  (151 mg, 0.300 mmol), after 3 hours 
an unseparable mixture of mono-di products 5-
Iodo-1-methyl-2-(2,4,6-trimethoxyphenyl)-1H-
indole 7b and and 5-iodo-1-methyl-2,3-
bis(2,4,6-trimethoxyphenyl)-1H-indole 7b’ 
(88.0 mg, 0.207 mmol, 69% yield, 9:1 major-mono:minor-di) were obtained as yellow oil. Rf: 
0.38 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 1.7 Hz, 1H, ArH major), 
7.81 (d, J = 1.7 Hz, 1H, ArH minor), 7.48 (dd, J = 8.6, 1.7 Hz, 1H, ArH minor), 7.42 (dd, J = 
8.5, 1.7 Hz, 1H, ArH major), 7.11 (d, J = 8.6 Hz, 1H, ArH major), 7.07 (d, J = 8.8 Hz, 1H, ArH 
minor), 6.38 (s, 1H, ArH major), 6.24 (s, 2H, ArH major), 6.20 (s, 2H, ArH minor), 3.90 (s, 
4.3H, OMe major  + OMe minor), 3.82 (s, 3H, OMe minor), 3.73 (s, 6.8H, OMe major + 2xOMe 
minor), 3.54 (s, 3H, NMe minor), 3.48 (s, 3H, NMe major). 13C NMR (101 MHz, CDCl3) major 
162.1, 159.9 (2 aromatic carbon signals overlapped), 136.2, 134.2, 130.5, 128.9, 128.7, 111.3, 
101.7, 90.6, 82.4, 55.8, 55.4, 30.2. minor 162.8, 160.0, 159.4, 156.5, 137.4, 136.4, 132.7, 130.1, 
129.6, 111.6, 102.3, 91.5, 90.7, 83.2, 59.7, 56.3, 55.8, 55.5, 31.2 (two aromatic carbon not 
resolved). IR ν 3006 (w), 2937 (w), 2838 (w), 1613 (s), 1587 (m), 1467 (s), 1415 (m), 1229 
(m), 1128 (s), 1065 (w), 950 (w), 817 (w), 791 (m).  HR-ESI-MS mono: 
C18H19INO3
+ [M+H]+ 424.0404; found 424.0412, di not detected. 
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1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,4,6-trimethoxyphenyl)-1H-
indole (7c) 
Following procedure GP7: using IndoleBX reagent 2d  (151 mg, 
0.300 mmol), after 3 hours 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-2-(2,4,6-trimethoxyphenyl)-1H-indole 7c (68.3 
mg, 0.161 mmol, 54% yield) was obtained as a yellow oil. Rf: 0.40 
(Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1H, 
ArH), 7.63 (dd, J = 8.3, 1.2 Hz, 1H, ArH), 7.32 (d, J = 8.3 Hz, 1H, ArH), 6.47 (s, 1H, ArH), 
6.23 (s, 2H, ArH), 3.89 (s, 3H, OMe), 3.71 (s, 6H, OMe), 3.50 (s, 3H, NMe), 1.37 (s, 12H, BPin-
Me). 13C NMR (101 MHz, CDCl3) δ 161.9, 160.0 (two aromatic carbon signals overlap), 
139.1, 133.3, 128.3, 127.8, 126.8, 108.6, 103.2, 102.9, 90.7, 83.2, 55.8 (two methoxy carbon 
signals overlap), 55.4, 30.1, 24.9. IR ν 2976 (w), 2935 (w), 2840 (w), 1610 (m), 1584 (m), 
1354 (s), 1327 (s), 1204 (m), 1125 (s), 1064 (m), 966 (w), 860 (m). HR-ESI-MS calcd for 
C24H31BNO5
+ [M+H]+ 424.2290; found 424.2289. 
 
1,2-Dimethyl-3-(2,4,6-trimethoxyphenyl)-1H-indole (7d) 
Following procedure GP7: using IndoleBX reagent 2b  (117 mg, 0.300 
mmol), after 3 hours 1,2-dimethyl-3-(2,4,6-trimethoxyphenyl)-1H-indole 
7d (37.1 mg, 0.120 mmol, 40% yield) was obtained as a yellow oil. Rf: 
0.52 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 7.27 (m, 1H, 
ArH), 7.21 (dt, J = 7.8, 1.0 Hz, 1H, ArH), 7.11 (ddd, J = 8.2, 7.0, 1.2 Hz, 
1H, ArH), 7.00 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 6.28 (s, 2H, ArH), 
3.90 (s, 3H, OMe), 3.71 (s, 9H, OMe + NMe) 2.25 (s, 3H, NCCH3). 13C NMR (101 MHz, 
CDCl3) δ 160.3, 159.3, 136.7, 135.2, 127.7, 120.1, 119.7, 118.7, 108.7, 105.2, 104.6, 90.8, 55.7, 
55.4, 29.7, 11.6.  IR ν 3002 (w), 2942 (w), 2837 (w), 1606 (m), 1585 (m), 1469 (m), 1414 (w), 
1205 (s), 1126 (s), 1062 (w), 956 (w), 739 (m). HR-ESI-MS calcd for 
C19H22NO3
+ [M+H]+ 312.1594; found 312.1596. 
 
1-Methyl-2-(2,4,6-trimethoxyphenyl)-1H-pyrrole (7e) 
 Following procedure GP7: using PyrroleBX reagent 2e or 2e’ (98.0 mg, 
0.300 mmol), after 3 hours 1-methyl-2-(2,4,6-trimethoxyphenyl)-1H-
pyrrole 7e (52.4 mg, 0.212 mmol, 71% yield) was obtained as a white 
solid. Rf: 0.60 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 6.72 
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(dd, J = 2.7, 1.8 Hz, 1H, ArH), 6.23 (dd, J = 3.5, 2.6 Hz, 1H, ArH), 6.19 (s, 2H, ArH), 6.07 (dd, 
J = 3.5, 1.7 Hz, 1H, ArH), 3.86 (s, 3H, CH3), 3.74 (s, 6H, CH3), 3.39 (s, 3H, CH3). 
1H-NMR 
values are in accordance with the data reported in literature.[24]  
 
1-Benzyl-2-(2,4,6-trimethoxyphenyl)-1H-pyrrole (7f) 
 Following procedure GP7: using PyrroleBX reagent 2f or 2f’ (121 
mg, 0.300 mmol), after 3 hours 1-benzyl-2-(2,4,6-
trimethoxyphenyl)-1H-pyrrole 7f (57.1 mg, 0.177 mmol, 59% 
yield) was obtained as a white solid. Rf: 0.58 (Pentane:EtOAc 
9:1). 1H NMR (400 MHz, CDCl3) δ 7.23 – 7.15 (m, 3H, ArH), 
7.04 – 6.98 (m, 2H, ArH), 6.73 (dd, J = 2.8, 1.8 Hz, 1H, ArH), 6.30 (t, J = 3.1 Hz, 1H, ArH), 
6.12 (s, 2H, ArH), 6.09 (m, 1H, ArH), 6.11 – 6.06 (m, 2H, ArCH2), 3.83 (s, 3H, OMe), 3.62 (s, 
6H, OMe). 1H-NMR values are in accordance with the data reported in literature.[24]  
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3.4.2: Scope of mixed 3’-2 biindoles. 
 
 
 
 
1,1'-Dimethyl-1H,1'H-2,3'-biindole (8a) 
Following procedure GP8: using commercially available N-
Methyl-Indole 5 (113 mg, 0.300 mmol), after 3 hours 1,1'-dimethyl-
1H,1'H-2,3'-biindole 8a (61.2 mg, 0.230 mmol, 77% yield) was 
obtained as a white solid. Rf: 0.40 (Pentane:EtOAc 9:1). 1H NMR 
(400 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 1H, ArH), 7.76 (d, J = 7.7 Hz, 1H, ArH), 7.50 – 7.46 
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(m, 2H, ArH), 7.42 (t, J = 7.6 Hz, 1H, ArH), 7.37 – 7.22 (m, 4H, ArH), 6.74 (s, 1H, ArH), 3.93 
(s, 3H, NMe), 3.84 (s, 3H, NMe). 1H-NMR values are in accordance with the data reported in 
literature.[25] 
 
1,1',5'-Trimethyl-1H,1'H-2,3'-biindole (8b) 
Following procedure GP8: using commercially available 1,5-
dimethyl-1H-indole (43.6 mg, 0.300 mmol), after 3 hours ,1',5'-
trimethyl-1H,1'H-2,3'-biindole 8b (52.6 mg, 0.192 mmol, 64% yield) 
was obtained as a yellow oil. Rf: 0.44 (Pentane:EtOAc 9:1). 1H NMR 
(400 MHz, CDCl3) δ 7.67 (dt, J = 7.8, 1.0 Hz, 1H, ArH), 7.51 (dt, J = 
1.8, 0.9 Hz, 1H, ArH), 7.40 (m, 1H, ArH), 7.31 (d, J = 8.5 Hz, 1H, ArH), 7.25 (m, 1H, ArH), 
7.22 – 7.12 (m, 3H, ArH), 6.63 (s, 1H, ArH), 3.86 (s, 3H, NMe), 3.77 (s, 3H, NMe), 2.49 (s, 
3H, CH3).  13C NMR (101 MHz, CDCl3) δ 137.9, 135.3, 129.6, 128.5, 128.3, 127.9, 123.9, 
120.9, 120.0, 119.9, 119.9, 119.5, 109.3, 109.2, 106.6, 101.2, 33.0, 31.0, 21.5. IR ν 3050 (w), 
2916 (w), 1592 (w), 1467 (s), 1336 (m), 1249 (m), 1151 (w), 1015 (w), 788 (m), 749 (s). HR-
ESI-MS calcd for C19H19N2
+ [M+H]+ 275.1543; found 275.1539. 
 
5'-Methoxy-1,1'-dimethyl-1H,1'H-2,3'-biindole (8c) and 5'-methoxy-1,1'-dimethyl-
1H,1'H-2,7'-biindole (8c’) 
Following procedure GP8: using 5-methoxy-
1-methyl-1H-indole 34b (48.4 mg, 0.300 
mmol), after 3 hours, 5'-methoxy-1,1'-
dimethyl-1H,1'H-2,3'-biindole 8c and 5'-
methoxy-1,1'-dimethyl-1H,1'H-2,7'-biindole 
8c’ (57.1 mg, 0.197 mmol, 65% yield, ratio major 8c: minor 8c' 12:1) were obtained as an 
unseparable mixture of yellow oil. Rf: 0.60 (Pentane:DCM 1:1). 1H NMR (400 MHz, CDCl3) 
δ 7.69 – 7.68 (m, 1H, ArH minor), 7.65 (dd, J = 7.8, 1.0 Hz, 1H, ArH major), 7.52 (s, 1H, ArH 
minor), 7.39 (d, J = 8.3 Hz, 1H ArH major + 1H ArH minor), 7.29 (d, J = 8.8 Hz, 1H ArH 
major + 2H ArH minor), 7.25 – 7.22 (m, 1H ArH major + 1H ArH minor), 7.18 (br s, 1H, ArH 
major), 7.15 (td, J = 7.5, 7.1, 1.0 Hz, 1H, ArH major), 7.12 (d, J = 2.4 Hz, 1H, ArH major), 
6.97 (dd, J = 8.9, 2.5 Hz, 1H, ArH major), 6.92 (d, J = 2.4 Hz, 1H, ArH minor), 6.60 (br s, 1H, 
ArH major – fast exchange with CDCl3), 3.89 (s, 3H, CH3 minor), 3.87 (s, 3H, CH3 major), 
3.82 (s, 3H, CH3 major), 3.80 (s, 3H, CH3 minor), 3.76 (s, 3H, CH3 major), 3.69 (s, 3H, CH3 
minor).13C NMR (101 MHz, CDCl3) δ major: 154.8, 137.9, 132.2, 129.0, 129.0, 128.3, 128.1, 
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121.0, 120.0, 119.6, 112.9, 110.4, 109.3, 106.8, 101.6, 55.9, 33.2, 31.0 (one aromatic carbon 
signal not resolved - minor not resolved). IR ν  3004 (w), 2950 (w), 2828 (w), 1668 (w), 1623 
(m), 1542 (m), 1489 (s), 1421 (w), 1288 (m), 1220 (m), 1140 (m), 1025 (w), 901 (m), 798 (s). 
HR-ESI-MS calcd for C19H19N2O
+ [M+H]+ 291.1492; found 291.1486. 
 
5'-Chloro-1,1'-dimethyl-1H,1'H-2,3'-biindole (8d) 
Following procedure GP8: using 5-chloro-1-methyl-1H-indole 34d 
(49.7 mg, 0.300 mmol), after 3 hours 5'-chloro-1,1'-dimethyl-1H,1'H-
2,3'-biindole 8d (63.4 mg, 0.215 mmol, 72% yield) was obtained as a 
yellow oil. Rf: 0.38 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, 
CDCl3) δ 7.66 (dd, J = 2.0, 0.7 Hz, 1H, ArH), 7.64 (dt, J = 7.9, 1.1 Hz, 
1H, ArH), 7.35 (dd, J = 8.2, 0.9 Hz, 1H, ArH), 7.27 (dd, J = 8.8, 0.7 Hz, 1H, ArH), 7.26 – 7.21 
(m, 2H, ArH), 7.17 – 7.12 (m, 2H, ArH), 6.60 (s, 1H, ArH), 3.82 (s, 3H, NMe), 3.71 (s, 3H, 
NMe). 13C NMR (101 MHz, CDCl3) 137.9, 135.3, 134.1, 129.4, 128.6, 128.2, 126.2, 122.6, 
121.2, 120.1, 119.6, 119.6, 110.6, 109.3, 107.0, 101.6, 33.2, 30.9. δ. IR ν 3054 (w), 2942 (w), 
2885 (w), 1590 (m), 1586 (m), 1466 (s), 1369 (m), 1271 (s), 1244 (m), 1145 (m), 1092 (m), 
795 (s). HR-ESI-MS calcd for C18H16ClN2
+ [M+H]+ 295.0997; found 295.0995. 
 
5'-Iodo-1,1'-dimethyl-1H,1'H-2,3'-biindole (8e). 
Following procedure GP8: using 5-iodo-1H-indole 34e (77.0 mg, 
0.300 mmol), after 3 hours 5'-iodo-1,1'-dimethyl-1H,1'H-2,3'-biindole 
8e (82.5 mg, 0.214 mmol, 71% yield) was obtained as a yellow oil. 
Rf: 0.40 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 7.93 
(dd, J = 1.7, 0.5 Hz, 1H, ArH), 7.56 (dt, J = 7.8, 1.1 Hz, 1H, ArH), 
7.45 (dd, J = 8.6, 1.7 Hz, 1H, ArH), 7.28 (m, 1H, ArH), 7.16 (m, 1H, ArH), 7.09 – 7.04 (m, 2H, 
ArH), 7.03 (s, 1H, ArH), 6.51 (d, J = 0.8 Hz, 1H, ArH), 3.74 (s, 3H, NMe), 3.63 (s, 3H, NMe). 
13C NMR (101 MHz, CDCl3) δ 137.9, 136.0, 134.0, 130.6, 130.1, 129.0, 128.9, 128.2, 121.2, 
120.1, 119.7, 111.5, 109.4, 106.7, 101.7, 83.8, 33.1, 30.9. IR ν 2931 (m), 2855 (m), 1828 (w), 
1730 (s), 1655 (w), 1524 (w), 1436 (s), 1333 (m), 1278 (s), 1199 (s), 1058 (m), 992 (m), 897 
(m), 762 (w). HR-ESI-MS calcd for C18H16IN2
+ [M+H]+ 387.0353; found 387.0355. 
 
1,1'-Dimethyl-5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-biindole (8f) 
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Following procedure GP8: using commercially available 1-methyl-5-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole  (77.0 mg, 
0.300 mmol), after 3 hours 1,1'-dimethyl-5'-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H,1'H-2,3'-biindole 8f (79.2 mg, 0.205 mmol, 
68% yield) was obtained as a yellow oil. Rf: 0.38 (Pentane:EtOAc 
9:1). 1H NMR (400 MHz, CDCl3) δ 8.19 (s, 1H, ArH), 7.78 (dd, J = 8.3, 1.1 Hz, 1H, ArH), 
7.68 (dt, J = 7.8, 1.0 Hz, 1H, ArH), 7.41 (dd, J = 4.8, 0.9 Hz, 1H, ArH), 7.39 (dd, J = 4.7, 0.9 
Hz, 1H, ArH), 7.25 (m, 1H, ArH), 7.18 (s, 1H, ArH), 7.15 (m, 1H, ArH), 6.66 (d, J = 0.8 Hz, 
1H, ArH), 3.88 (s, 3H, NMe), 3.75 (s, 3H, NMe), 1.36 (s, 12H, BPin-Me). 13C NMR (101 MHz, 
CDCl3) δ 138.8, 137.9, 134.7, 128.5, 128.4, 128.3, 128.0, 127.5, 121.0, 120.0, 119.5, 109.3, 
108.8, 108.0, 101.8, 83.5, 60.4, 33.0, 30.9, 24.8. NB: the Carbon-Boron bond is not observed 
as reported in literature.[18] IR ν 3050 (w), 2978 (w), 2927 (w), 1614 (w), 1466 (m), 1352 (s), 
1311 (m), 1143 (s), 1095 (m), 968 (w), 866 (m), 737 (s). HR-ESI-MS calcd for 
C24H28BN2O2
+ [M+H]+ 387.2238; found 387.2244. 
 
1,1'-Dimethyl-1H,1'H-[2,3'-biindol]-6'-ol (8g) 
Following procedure GP8: using 6-(benzyloxy)-1-methyl-1H-
indole 34e (77.0 mg, 0.300 mmol), after 3 hours 1,1'-dimethyl-
1H,1'H-[2,3'-biindol]-6'-ol 8g (57.8 mg, 0.209 mmol, 70% yield) 
was obtained as a yellow oil. Rf: 0.28 (Pentane:EtOAc 9:1). 1H 
NMR (400 MHz, CDCl3) δ 7.65 (d, J = 7.8 Hz, 1H, ArH), 7.54 (d, J = 8.5 Hz, 1H, ArH), 7.37 
(m, 1H, ArH), 7.24 (m, 1H, ArH), 7.15 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 7.07 (s, 1H, ArH), 
6.83 (d, J = 2.3 Hz, 1H, ArH), 6.74 (dd, J = 8.5, 2.3 Hz, 1H, ArH), 6.61 (s, 1H, ArH), 4.97 (br 
s, 1H, OH), 3.77 (s, 3H, NMe), 3.76 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) δ 152.3, 137.9, 
137.8, 135.1, 128.3, 127.3, 122.2, 121.1, 120.9, 119.9, 119.5, 110.2, 109.3, 107.4, 101.2, 95.3, 
33.0, 30.9. IR ν 3369 (w), 2941 (w), 2900 (w), 1627 (s), 1593 (s), 1463 (m), 1395 (m), 1320 
(m), 1234 (m), 1183 (m), 1171 (m), 1081 (m), 966 (s), 780 (s). HR-ESI-MS calcd for calcd for 
C18H17N2O
+ [M+H]+ 277.1335; found 277.1344. 
 
1-Methyl-1H,1'H-2,3'-biindole (8h) 
Following procedure GP8: using commercially available 1H-indole  
(35.1 mg, 0.300 mmol), after 3 hours 1-methyl-1H,1'H-2,3'-biindole 8h 
(48.3 mg, 0.196 mmol, 65% yield) was obtained as a yellow oil. Rf: 0.50 
(Pentane:EtOAc 1:1). 1H NMR (400 MHz, CDCl3) δ 8.38 (br s, 1H, 
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NH), 7.72 (d, J = 8.0 Hz, 1H, ArH), 7.66 (d, J = 7.8 Hz, 1H, ArH), 7.48 (d, J = 8.2 Hz, 1H, 
ArH), 7.43 – 7.33 (m, 2H, ArH), 7.33 – 7.10 (m, 4H, ArH), 6.66 (s, 1H, ArH), 3.71 (s, 3H, 
NMe) (NB: the product is highly unstable under atmosphere – presence of grease in the proton 
NMR).   13C NMR (101 MHz, CDCl3) δ 138.1, 136.1, 135.1, 128.4, 127.3, 124.0, 122.9, 121.2, 
120.8, 120.3, 120.2, 119.7, 111.5, 109.5, 109.0, 101.7, 31.1. IR ν 3402 (m), 3058 (w), 2926 
(w), 2846 (w), 1593 (w), 1458 (m), 1329 (w), 1242 (m), 1097 (m), 1011 (w), 784 (m), 747 (s). 
HR-ESI-MS calcd for C17H15N2
+ [M+H]+ 247.1230; found 247.1226. 
5'-Fluoro-1-methyl-1H,1'H-2,3'-biindole (8i) 
Following procedure GP8: using commercially available 5-fluoro-1H-
indole (40.5 mg, 0.300 mmol), after 3 hours 5'-fluoro-1-methyl-1H,1'H-
2,3'-biindole 8i (62.0 mg, 0.235 mmol, 78% yield) was obtained as a 
yellow resin. Rf: 0.42 (Pentane:EtOAc 1:1). 1H NMR (400 MHz, 
CDCl3) δ 8.35 (br s, 1H), 7.67 (d, J = 7.7 Hz, 1H, ArH), 7.42 – 7.32 (m, 
4H, ArH), 7.26 (m, 1H, ArH), 7.17 (t, J = 7.4 Hz, 1H, ArH), 7.04 (td, J = 9.0, 2.5 Hz, 1H, ArH), 
6.64 (s, 1H, ArH), 3.75 (s, 3H, NMe) (NB: the product is highly unstable under atmosphere – 
presence of grease in the proton NMR).  13C NMR (101 MHz, CDCl3) δ 158.51 (d, J = 236.2 
Hz), 137.9, 134.3, 132.5, 128.6, 128.2, 127.63 (d, J = 8.5 Hz), 127.0, 125.4, 121.2, 119.90 (d, 
J = 46.8 Hz), 112.05 (d, J = 7.3 Hz), 111.31 (d, J = 26.3 Hz), 105.10 (d, J = 24.2 Hz), 101.6, 
30.9. IR ν 3433 (w), 3400 (m), 3050 (w), 1583 (m), 1486 (s), 1467 (s), 1387 (w), 1281 (m), 
1243 (m), 1163 (m), 930 (m), 744 (s). HR-ESI-MS calcd for C17H14FN2
+ [M+H]+ 265.1136; 
found 265.1137. 
 
5'-Bromo-1-methyl-1H,1'H-2,3'-biindole (8j) 
Following procedure GP8: using commercially available 5-bromo-1H-
indole  (58.8 mg, 0.300 mmol), after 3 hours 5'-bromo-1-methyl-
1H,1'H-2,3'-biindole 8j (60.8 mg, 0.187 mmol, 62% yield) was obtained 
as a yellow resin. Rf: 0.40 (Pentane:EtOAc 1:1). 1H NMR (400 MHz, 
CDCl3) δ 8.32 (br s, 1H, NH), 7.81 (d, J = 1.8 Hz, 1H, ArH), 7.65 (d, J 
= 7.8 Hz, 1H, ArH), 7.35 (m, 2H, ArH), 7.28 (s, 1H, ArH), , 7.28 – 7.22 (m, 2H, ArH), 7.15 
(td, J = 7.5, 1.1 Hz, 1H, ArH), 6.62 (s, 1H, ArH), 3.70 (s, 3H, NMe). 13C NMR (101 MHz, 
CDCl3) δ 137.9, 134.6, 133.9, 128.9, 128.2, 125.7, 124.8, 122.7, 121.3, 120.2, 119.7, 114.0, 
112.8, 109.4, 108.6, 101.9, 30.9. IR ν 3399 (w), 3157 (w), 2987 (w), 2888 (w), 1621 (w), 1535 
(w), 1477 (m), 1429 (m), 1267 (s), 1224 (s), 1090 (s), 1024 (s), 885 (m), 761 (m).  HR-ESI-
MS calcd for C17H14
79BrN2
+ [M+H]+ 325.0335; found 325.0329. 
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1,1',3-Trimethyl-1H,1'H-2,3'-biindole (8k) 
Following procedure GP8: using commercially available 1,3-
dimethyl-1H-indole (43.6 mg, 0.300 mmol), after 3 hours 1,1',3-
trimethyl-1H,1'H-2,3'-biindole 8k (36.9 mg, 0.134 mmol, 45% yield) 
was obtained as a yellow oil. Rf: 0.44 (Pentane:EtOAc 9:1). 1H NMR 
(400 MHz, CDCl3) δ 7.62 (dt, J = 7.9, 1.0 Hz, 1H, ArH), 7.46 (dt, J = 
7.2, 0.7 Hz, 1H, ArH), 7.44 (m, 1H, ArH), 7.36 (dt, J = 8.0, 0.9 Hz, 1H, ArH), 7.32 (ddd, J = 
8.2, 7.0, 1.2 Hz, 1H, ArH), 7.17 (m, 2H, ArH), 7.15 (m, 2H, ArH), 3.92 (s, 3H, NMe), 3.63 (s, 
3H, NMe), 2.29 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 137.3, 136.9, 131.5, 129.4, 128.6, 
128.2, 122.0, 121.1, 120.5, 119.9, 118.7, 118.5, 109.5, 109.1, 109.0, 106.1, 33.0, 30.8, 9.7. IR 
ν 3422 (s), 1592 (m), 1493 (w), 1442 (w), 1360 (w), 1287 (w), 1222 (w), 1144 (w), 1025 (m). 
HR-ESI-MS calcd for C19H19N2
+ [M+H]+ 275.1543; found 275.1542. 
 
2-(1'-Methyl-1H,1'H-[2,3'-biindol]-3-yl)ethanol (8l) 
Following procedure GP8: using commercially available 2-(1H-indol-
3-yl)ethanol (48.4 mg, 0.300 mmol), after 3 hours 2-(1'-methyl-
1H,1'H-[2,3'-biindol]-3-yl)ethanol 8l (49.8 mg, 0.172 mmol, 57% 
yield) was obtained as a yellow oil. Rf: 0.60 (Pentane:EtOAc 1:1). 1H 
NMR (400 MHz, CDCl3) δ 8.23 (br s, 1H, NH), 7.78 (dt, J = 7.9, 1.0 
Hz, 1H, ArH), 7.68 – 7.59 (m, 1H, ArH), 7.46 (s, 1H, ArH), 7.41 (m, 2H, ArH), 7.32 (ddd, J = 
8.2, 6.9, 1.2 Hz, 1H, ArH), 7.21 (m, 2H, ArH), 7.16 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H, ArH), 3.95 
(t, J = 6.4 Hz, 2H, CH2), 3.86 (s, 3H, NMe), 3.15 (t, J = 6.4 Hz, 2H, CH2), 1.55 (s, 1H, OH). 
13C NMR (101 MHz, CDCl3) δ 137.0, 135.9, 131.3, 128.9, 128.5, 126.8, 122.4, 121.6, 120.2, 
119.6, 119.5, 118.4, 110.7, 109.7, 107.7, 106.8, 62.9, 33.0, 28.3. IR ν 2926 (w), 2866 (w), 1550 
(s), 1528 (s), 1507 (s), 1475 (s), 1325 (s), 1276 (s), 1263 (s), 1193 (s), 1159 (s), 1116 (m), 1068 
(m), 1003 (m), 930 (s), 886 (m), 811 (m). HR-ESI-MS calcd for 
C19H18N2NaO
+ [M+Na]+ 313.1311; found 313.1314. 
 
5-Iodo-1,1'-dimethyl-1H,1'H-2,3'-biindole (8m) 
Following procedure GP8: using commercially available 
methylindole 5 (39.4 mg, 0.300 mmol) and IndoleBX 2c (151 mg, 
0.300 mmol), after 3 hours 5-iodo-1,1'-dimethyl-1H,1'H-2,3'-
biindole 8m (58.9 mg, 0.152 mmol, 51% yield) was obtained as a 
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yellow oil. Rf: 0.35 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 1.6 Hz, 
1H, ArH), 7.69 (d, J = 8.0 Hz, 1H, ArH), 7.48 (dd, J = 8.6, 1.7 Hz, 1H, ArH), 7.42 (d, J = 8.3 
Hz, 1H, ArH), 7.34 (m, 1H, ArH), 7.23 (m, 1H, ArH), 7.20 (s, 1H, ArH), 7.15 (d, J = 8.5 Hz, 
1H, ArH), 6.55 (s, 1H, ArH), 3.89 (s, 3H, NMe), 3.73 (s, 3H, NMe). 13C NMR (101 MHz, 
CDCl3) δ 137.0, 136.9, 136.0, 130.9, 129.1, 128.6, 128.5, 127.5, 122.4, 120.4, 120.2, 111.3, 
109.6, 106.7, 100.5, 83.0, 33.1, 31.1. IR ν  048 (w), 2928 (w), 1734 (w), 1618 (m), 1589 (m), 
1467 (m), 1392 (m), 1372 (m), 1265 (m), 1248 (m), 1133 (w), 1089 (w), 1044 (w), 951 (w), 
897 (w), 871 (w), 787 (m), 741 (s). HR-ESI-MS) calcd for C18H16IN2
+ [M+H]+ 387.0353; 
found 387.0356. 
 
5'-Methoxy-1,1'-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-
biindole (8n). 
Following procedure GP8: using 5-methoxy-1-methyl-1H-
indole 34b (48.4 mg, 0.300 mmol) and IndoleBX 2d (151 mg, 
0.300 mmol), after 3 hours 5'-methoxy-1,1'-dimethyl-5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-biindole 8n 
(69.0 mg, 0.166 mmol, 55% yield) was obtained as a yellow oil. 
Rf: 0.15 (Pentane:DCM 1:1). 1H NMR (400 MHz, CDCl3) δ 8.18 (s, 1H, ArH), 7.68 (dd, J = 
8.2, 1.2 Hz, 1H, ArH), 7.37 (d, J = 8.2 Hz, 1H, ArH), 7.29 (d, J = 8.9 Hz, 1H, ArH), 7.17 (s, 
1H, ArH), 7.09 (d, J = 2.5 Hz, 1H, ArH), 6.96 (dd, J = 8.9, 2.5 Hz, 1H, ArH), 6.62 (s, 1H, ArH), 
3.86 (s, 3H, NMe), 3.81 (s, 3H, NMe), 3.75 (s, 3H, NMe), 1.38 (s, 12H, BPin). 13C NMR (101 
MHz, CDCl3) δ 154.8, 139.8, 135.3, 132.2, 128.9, 128.1, 128.1, 127.9, 127.2, 112.9, 110.4, 
108.7, 106.7, 101.8, 101.4, 83.4, 55.9, 33.2, 30.9, 24.9. NB: the Carbon-Boron bond is not 
observed as reported in literature.[18] IR ν 2996 (m), 2867 (w), 2837 (w), 1521 (m), 1431 (m), 
1361 (w), 1288 (m), 1148 (w), 991 (s), 862 (s). HR-ESI-MS calcd for C25H29BN2O3
+ [M+] 
416.2094; found 416.2286. 
 
5'-Nitro-1,1'-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-
biindole (8o) 
Following procedure GP8: using commercially available 1-
methyl-5-nitro-1H-indole (53.0 mg, 0.300 mmol) and IndoleBX 
2d (151 mg, 0.300 mmol), after 3 hours 5'-nitro-1,1'-dimethyl-5-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-
biindole 8o (65.4 mg, 0.152 mmol, 51% yield) was obtained as 
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an orange oil. Rf: 0.20 (Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 8.62 (s, 1H, ArH), 
8.25 – 8.15 (m, 2H, ArH), 7.72 (m, 1H, ArH), 7.44 – 7.35 (m, 2H, ArH), 7.34 (d, J = 1.3 Hz, 
1H, ArH), 6.66 (s, 1H, ArH), 3.94 (s, 3H, NMe), 3.75 (s, 3H, NMe), 1.39 (s, 12H, BPin-Me). 
13C NMR (101 MHz, CDCl3) δ 142.3, 140.0, 139.5, 132.8, 131.1, 128.2, 127.8 (2 aromatic 
carbon signals overlapped), 127.0, 118.0, 117.6, 110.1, 109.6, 108.9, 103.0, 83.4, 33.5, 31.0, 
24.9. NB: the Carbon- bound to Boron is not observed as reported in literature.[18] IR ν 3482 
(w), 3333 (w), 3090 (w), 1519 (s), 1330 (s), 1282 (m), 1149 (m), 995 (m), 931 (s), 856 (s), 833 
(s). HR-ESI-MS calcd for C24H26BN3NaO4
+ [M+Na]+ 454.1909; found 454.1914. 
 
3.4.3: Scope of pyrrole- and thiophene-2-methylindoles. 
 
 
 
1-Methyl-2-(1-methyl-1H-pyrrol-2-yl)-1H-indole (9a) 
Following procedure GP8: using commercially available 1-methyl-1H-
pyrrole (27.0 µL, 0.300 mmol), after 3 hours 1-methyl-2-(1-methyl-1H-
pyrrol-2-yl)-1H-indole 9a (44.3 mg, 0.211 mmol, 70% yield) was obtained 
as a yellow oil. Rf: 0.70 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, J = 7.9 Hz, 1H, ArH), 7.36 (d, J = 8.2 Hz, 1H, ArH), 7.26 (m, 1H, ArH), 7.15 
(ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 6.81 (dd, J = 2.7, 1.8 Hz, 1H, ArH), 6.53 (s, 1H, ArH), 
6.30 (dd, J = 3.6, 1.7 Hz, 1H, ArH), 6.27 (dd, J = 3.6, 2.6 Hz, 1H, ArH), 3.66 (s, 3H, NMe), 
3.60 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) δ 137.5, 132.2, 127.6, 124.5, 123.6, 121.7, 
120.4, 119.7, 111.4, 109.5, 107.8, 103.2, 34.7, 30.6. IR ν 3050 (w), 2984 (w), 2887 (w), 1614 
S54 
 
(w), 1471 (w), 1384 (w), 1259 (m), 1047 (m), 959 (s), 785 (m). HR-ESI-MS calcd for 
C14H15N2
+ [M+H]+ 211.1230; found 211.1227. 
 
1-Methyl-2-(1-phenyl-1H-pyrrol-2-yl)-1H-indole 9b and 1-methyl-2-(1-phenyl-1H-
pyrrol-3-yl)-1H-indole (9b’) 
Following procedure GP8: using commercially 
available 1-phenyl-1H-pyrrole  (43.0 µL, 0.300 
mmol), after 3 hours  a separable mixture of 1-
methyl-2-(1-phenyl-1H-pyrrol-2-yl)-1H-indole 
9b (26.2 mg, 96.0 µmol, 32% yield) and 1-methyl-2-(1-phenyl-1H-pyrrol-3-yl)-1H-indole 9b’ 
(24.1 mg, 88.0 µmol, 30% yield) was obtained as a yellow oil.  
 
9b Rf: 0.40 (Pentane:EtOAc 9:1) 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 7.9 Hz, 1H, ArH), 
7.29 – 7.13 (m, 7H, ArH), 7.13 – 7.06 (m, 2H, ArH), 6.50 (dd, J = 3.5, 1.8 Hz, 1H, ArH), 6.44 
(t, J = 3.2 Hz, 1H, ArH), 6.42 (s, 1H, ArH), 3.34 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) 
δ 140.2, 137.4, 132.6, 129.1, 127.8, 126.4, 124.3, 124.2, 123.7, 121.5, 120.4, 119.5, 114.0, 
109.4 (2 aromatic carbon signals overlapped), 103.5, 30.5. IR ν 3106 (w), 2978 (w), 2901 (w), 
1558 (s), 1489 (s), 1371 (s), 1292 (s), 1218 (s), 1054 (m), 818 (s). HR-ESI-MS calcd for 
C19H17N2
+ [M+H]+ 273.1386; found 273.1379. 
 
9b’  Rf: 0.38 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.0 Hz, 1H, 
ArH), 7.30 – 7.18 (m, 7H, ArH), 7.07 (ddd, J = 8.0, 6.9, 1.2 Hz, 1H, ArH), 6.96 (dd, J = 2.9, 
1.8 Hz, 1H, ArH), 6.51 (m, 1H, ArH), 6.49 (s, 1H, ArH), 6.42 (dd, J = 3.5, 2.8 Hz, 1H, ArH), 
3.66 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) δ 140.8, 136.5, 128.7, 127.4, 127.3, 127.1, 
126.4, 125.7, 122.6, 121.7, 120.4, 119.5, 109.9, 109.1, 109.0, 107.7, 32.7. IR ν 3106 (w), 3045 
(w), 1599 (m), 1499 (s), 1426 (w), 1366 (m), 1321 (m), 1254 (w), 1103 (w), 912 (w), 743 (s). 
HR-ESI-MS calcd for C19H17N2
+ [M+H]+ 273.1386; found 273.1386. 
 
2-(3-Methoxythiophen-2-yl)-1-methyl-1H-indole (10a) 
Following procedure GP8: using commercially available 3-
methoxythiophen (30.0 mg, 0.300 mmol), after 3 hours 2-(3-
methoxythiophen-2-yl)-1-methyl-1H-indole 10a (46.8 mg, 0.192 mmol, 
64% yield) was obtained as a yellow oil. Rf: 0.80 (Pentane:EtOAc 4:1). 1H 
NMR (400 MHz, CDCl3) δ 7.62 (d, J = 7.8 Hz, 1H, ArH), 7.36 (m, 1H, ArH), 7.31 (d, J = 5.5 
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Hz, 1H, ArH), 7.24 (m, 1H, ArH), 7.12 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H, ArH), 6.96 (d, J = 5.5 
Hz, 1H, ArH), 6.62 (s, 1H, ArH), 3.85 (s, 3H, NMe), 3.73 (s, 3H, OMe). 13C NMR (101 MHz, 
CDCl3) δ 154.8, 137.9, 131.5, 127.8, 124.7, 121.7, 120.4, 119.6, 116.7, 110.4, 109.4, 103.5, 
58.7, 30.8. IR ν 3108 (w), 2935 (w), 2851 (w), 1583 (w), 1465 (m), 1378 (s), 1337 (m), 1252 
(s), 1103 (w), 1070 (s), 929 (w), 780 (m), 750 (s). HR-ESI-MS calcd for 
C14H14NOS
+ [M+H]+ 244.0791; found 244.0787. 
 
2-(2,5-Dimethylthiophen-3-yl)-1-methyl-1H-indole (10b) 
Following procedure GP8: using commercially available 2,5-
dimethylthiophene  (34.0 mg, 0.300 mmol), after 3 hours 2-(2,5-
dimethylthiophen-3-yl)-1-methyl-1H-indole 10b (35.2 mg, 0.146 
mmol, 49% yield) was obtained as a yellow oil. Rf: 0.85 
(Pentane:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 7.9 Hz, 1H, ArH), 7.35 (m, 
1H, ArH), 7.29 – 7.24 (m, 1H, ArH), 7.14 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 7.03 (s, 1H, 
ArH), 6.85 (d, J = 1.3 Hz, 1H, ArH), 3.84 (s, 3H, NMe), 2.48 (s, 3H, CH3), 2.43 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 136.7, 135.2, 131.2, 130.9, 127.6, 127.3, 127.1, 121.7, 120.3, 
119.3, 111.4, 109.2, 32.8, 15.3, 14.2. IR ν 3499 (w), 2919 (s), 2854 (m), 1685 (w), 1484 (m), 
1332 (w), 1218 (m), 1137 (s), 1015 (m), 815 (m). HR-APPI-MS calcd for C15H15NS [M+] 
241.0920; found 241.0926. 
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3.4.4: Scope of trimethoxy(methyl)phenylated-NH-indoles. 
 
 
2-(2,4,6-Trimethoxyphenyl)-1H-indole (14a) 
Following procedure GP9: starting from C2-IndoleDBX 13c (95.5 
mg, 0.200 mmol, 1.00 equiv.), after 3 hours 2-(2,4,6-
trimethoxyphenyl)-1H-indole 14a (43.4 mg, 0.150 mmol, 77% yield) 
was obtained as a grey solid. M.p. 132-137 °C. Rf: 0.55 
(Pentane:EtOAc 8:2). 1H NMR (400 MHz, CDCl3) δ 9.47 (s, 1H, NH), 7.64 (dt, J = 7.8, 1.0 
Hz, 1H, ArH), 7.39 (dd, J = 8.0, 1.2 Hz, 1H, ArH), 7.16 (ddd, J = 8.1, 7.0, 1.3 Hz, 1H, ArH), 
7.11 – 7.07 (m, 2H, ArH), 6.29 (s, 2H, ArH), 3.93 (s, 6H, o-OCH3), 3.88 (s, 3H, p-OCH3). 13C 
NMR (101 MHz, CDCl3) δ 160.1, 158.7, 135.0, 131.2, 128.2, 121.1, 120.0, 119.1, 110.3, 103.7, 
103.6, 91.5, 56.0, 55.3.  IR ν 3434 (w), 2938 (w), 2837 (w), 1605 (m), 1583 (m), 1486 (w), 
1455 (s), 1414 (m), 1330 (m), 1204 (m), 1122 (s) HR-ESI-MS: calcd for C17H18NO3
+ 284.1281 
[M + H]+; found 284.1284.  
NB: when C2-IndoleBX 13a was used, the desired compound 14a was obtained in 67% yield. 
 
 
 
5-Methoxy-2-(2,4,6-trimethoxyphenyl)-1H-indole (14b) 
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Following procedure GP9: starting from C2-IndoleDBX 13e (101 mg, 0.200 mmol), after 3 
hours 5-methoxy-2-(2,4,6-trimethoxyphenyl)-1H-indole 14b (41.7 
mg, 0.130 mmol, 67% yield) was obtained as a green solid. M.p. 
115-120 °C. Rf: 0.45 (Pentane:EtOAc 8:2). 1H NMR (400 MHz, 
CDCl3) δ 9.38 (s, 1H, NH), 7.27 (d, J = 8.6 Hz, 1H, ArH), 7.11 (d, 
J = 2.4 Hz, 1H, ArH), 7.00 (s, 1H, ArH), 6.82 (dd, J = 8.7, 2.4 Hz, 
1H, ArH), 6.28 (s, 2H, ArH), 3.92 (s, 6H, o-OCH3), 3.87 (s, 6H, p-OCH3 ,and 5-OCH3). 13C 
NMR (101 MHz, CDCl3) δ 160.1, 158.6, 153.8, 131.9, 130.3, 128.5, 128.4, 111.5, 111.0, 103.6, 
101.7, 91.5, 56.0, 55.8, 55.3. IR ν 3431 (w), 2937 (w), 2841 (w), 1604 (m), 1580 (m), 1459 
(m), 1204 (s), 1120 (s), 1034 (m), 799 (s). HR-ESI-MS: calcd for C18H20NO4
+ 314.1387[M + 
H]+; found 314.1391. 
6-Methoxy-2-(2,4,6-trimethoxyphenyl)-1H-indole (14c) 
 Following procedure GP9: starting from C2-IndoleDBX 13f 
(101 mg, 0.200 mmol), after 3 hours 6-methoxy-2-(2,4,6-
trimethoxyphenyl)-1H-indole 14c (31.1 mg, 0.100 mmol, 50% 
yield) was obtained as a green solid. M.p 165-168 °C. Rf: 0.51 
(Pentane:EtOAc 8:2). 1H NMR (400 MHz, CDCl3) δ 9.38 (s, 
1H, NH), 7.49 (d, J = 8.6 Hz, 1H, ArH), 6.99 (dd, J = 2.1, 0.9 Hz, 1H, ArH), 6.90 (d, J = 2.3 
Hz, 1H, ArH), 6.76 (dd, J = 8.6, 2.3 Hz, 1H, ArH), 6.28 (s, 2H, ArH), 3.92 (s, 6H, o-OCH3), 
3.87 (s, 3H, OCH3 ), 3.86 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3) δ 159.8, 158.4, 155.9, 
135.6, 130.0, 122.6, 120.7, 109.2, 103.8, 103.6, 93.9, 91.5, 56.0, 55.6, 55.3. IR ν 3442 (s), 1604 
(s), 1479 (s), 1329 (s), 1303 (s), 1234 (s), 1116 (w). HR-ESI-MS: calcd for C18H20NO4
+ 
314.1387[M + H]+; found 314.1389. 
6-Bromo-2-(2,4,6-trimethoxyphenyl)-1H-indole (14d) 
Following procedure GP9: starting from C2-IndoleDBX 13g (111 
mg, 0.200 mmol), after 3 hours 6-bromo-2-(2,4,6-
trimethoxyphenyl)-1H-indole 14d (68.0 mg, 0.190 mmol, 94% 
yield) was obtained as a colorless solid. M.p. 133-138 °C. Rf: 0.49 
(Pentane:EtOAc 8:2). 1H NMR (400 MHz, CDCl3) δ 9.52 (s, 1H, 
NH), 7.53 (d, J = 1.8 Hz, 1H, ArH), 7.47 (d, J = 8.4 Hz, 1H, ArH), 7.16 (dd, J = 8.4, 1.7 Hz, 
1H, ArH), 7.03 (s, 1H, ArH), 6.28 (s, 2H, ArH), 3.93 (s, 6H, o-OCH3), 3.87 (s, 3H, p-OCH3). 
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13C NMR (101 MHz, CDCl3) δ 160.4, 158.7, 135.7, 132.2, 127.1, 122.4, 121.2, 114.4, 113.2, 
103.7, 102.9, 91.5, 56.0, 55.3. IR ν 3444 (w), 1605 (w), 1581 (w), 1454 (w), 1329 (w), 1205 
(w), 1115 (s), 1067 (m). HR-ESI-MS: calcd for C17H17Br
79NO3
+ 362.0386 [M + H]+; found 
362.0388. 
3-Methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole (14e) 
Following procedure GP9: starting from C2-IndoleDBX 13h (98.0 
mg, 0.200 mmol), after 3 hours 3-methyl-2-(2,4,6-trimethoxyphenyl)-
1H-indole 14e (49.0 mg, 0.160 mmol, 82% yield) was obtained as a 
pale yellow solid. M.p. 128-131 °C. Rf: 0.46 (Pentane:EtOAc 8:2). 1H 
NMR (400 MHz, CDCl3) δ 8.15 (s, 1H, NH), 7.68 (ddt, J = 7.5, 1.6, 
0.8 Hz, 1H, ArH), 7.41 (dt, J = 8.0, 1.0 Hz, 1H, ArH), 7.21 (dddd, J = 21.2, 8.2, 7.1, 1.2 Hz, 
2H, ArH), 6.34 (s, 2H, ArH), 3.98 (s, 3H, p-OCH3), 3.85 (s, 6H, o-OCH3), 2.28 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 161.5, 159.4, 135.9, 128.9, 127.1, 121.1, 118.5, 118.5, 110.8, 
110.4, 103.1, 90.7, 55.7, 55.3, 9.7. IR ν 3395 (w), 2939 (w), 2840 (w), 1609 (m), 1581 (m), 
1456 (m), 1412 (m), 1224 (m), 1126 (s), 1033 (m), 941 (m), 816 (w). HR-ESI-MS: calcd for 
C18H20NO3
+ 298.1438 [M + H]+; found 298.1440. 
2-(2-(2-(2,4,6-Trimethoxyphenyl)-1H-indol-3-yl)ethyl)isoindoline-1,3-dione (14f) 
 Following procedure GP9: starting from C2-IndoleDBX 13i (110 mg, 
0.200 mmol), after 3 hours 2-(2-(2-(2,4,6-trimethoxyphenyl)-1H-indol-
3-yl)ethyl)isoindoline-1,3-dione 14f (68.1 mg, 0.150 mmol, 75% yield) 
was obtained as an orange solid. M.p. 195-200 °C. Rf: 0.68 
(Pentane:EtOAc 8:2). 1H NMR (400 MHz, CDCl3) δ 8.08 (s, 1H, NH), 
7.90 (dd, J = 6.5, 2.3 Hz, 1H, ArH), 7.79 (dt, J = 7.0, 3.5 Hz, 2H, ArH), 7.68 (dd, J = 5.5, 3.0 
Hz, 2H, ArH), 7.35 (dt, J = 7.3, 2.1 Hz, 1H, ArH), 7.20 – 7.09 (m, 2H, ArH), 6.18 (s, 2H, ArH), 
4.01 – 3.99 (m, 2H, CH2), 3.87 (s, 3H, p-OCH3), 3.75 (s, 6H, o-OCH3), 3.03 – 2.99 (m, 2H, 
CH2). 13C NMR (101 MHz, CDCl3) δ 168.2, 161.6, 159.4, 135.9, 133.5, 132.3, 128.1, 128.0, 
122.9, 121.3, 119.0, 118.8, 111.1, 110.6, 102.4, 90.5, 55.7, 55.3, 37.7, 24.7. IR ν 3392 (w), 
1770 (w), 1704 (s), 1395 (s), 1359 (m), 1127 (m), 1042 (w). HR-ESI-MS: calcd for 
C27H25N2O5
+ 457.1758 [M + H]+; found 457.1766. 
 
2-(2,4,6-trimethoxy-3-methylphenyl)-1H-indole (14g) 
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Following procedure GP9: starting from C2-IndoleDBX 13c (95.5 mg, 0.200 mmol), after 3 
hours 2-(2,4,6-trimethoxy-3-methylphenyl)-1H-indole 14g (27.1 mg, 
90.0 µmol, 46% yield) was obtained as a white solid. M.p. 135-138 
°C. Rf: 0.62 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 9.46 
(s, 1H, NH), 7.64 (dd, J = 7.8, 1.3 Hz, 1H, ArH), 7.40 (d, J = 8.0 Hz, 
1H, ArH), 7.16 (ddd, J = 8.1, 7.0, 1.3 Hz, 1H, ArH), 7.09 (ddd, J = 8.0, 
7.0, 1.1 Hz, 2H, ArH), 6.41 (s, 1H, ArH), 3.92 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 3.53 (s, 3H, 
OCH3), 2.17 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 158.2, 157.4, 156.3, 135.3, 131.1, 
128.4, 121.3, 120.2, 119.3, 112.8, 110.4, 107.6, 103.7, 92.3, 60.2, 56.2, 55.6, 8.4. IR ν 3325 
(w), 2960 (w), 1611 (m), 1452 (m), 1201 (m), 1110 (s), 797 (m). HR-ESI-MS: calcd for 
C18H20NO3
+ 298.1438[M + H]+; found 298.1443. 
 
3-Methyl-2-(2,4,6-trimethoxy-3-methylphenyl)-1H-indole (14h) 
Following procedure GP9: starting from C2-IndoleDBX 13h (98.0 
mg, 0.200 mmol), after 3 hours 3-methyl-2-(2,4,6-trimethoxy-3-
methylphenyl)-1H-indole 14h (40.6 mg, 0.130 mmol, 65% yield) was 
obtained as a brown solid. M.p. 164-166 °C. Rf: 0.58 (Pentane:EtOAc 
8:2). 1H NMR (400 MHz, CDCl3) δ 8.18 (s, 1H, NH), 7.63 – 7.61 (m, 
1H, ArH), 7.35 (dt, J = 8.1, 1.0 Hz, 1H, ArH), 7.15 (dddd, J = 21.4, 8.1, 7.1, 1.2 Hz, 2H, ArH), 
6.39 (s, 1H, ArH), 3.92 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.30 (s, 3H, OCH3), 2.24 (s, 3H, 
CH3), 2.15 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 159.1, 158.3, 156.9, 136.0, 128.9, 
127.4, 121.3, 118.6, 118.5, 111.9, 110.8, 110.4, 107.4, 91.5, 60.0, 55.9, 55.6, 9.7, 8.4. IR ν 3353 
(w), 2935 (w), 1606 (w), 1449 (m), 1434 (m), 1326 (m), 1185 (m), 1111 (s), 1006 (w), 806 (m), 
736 (s). HR-ESI-MS: calcd for C19H22NO3
+ 312.1594 [M + H]+; found 312.1593. 
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3.4.5: Scope of mixed 3’-2-NH-biindoles. 
 
 
6'-Bromo-1H,1'H-2,3'-biindole (15a) 
Following procedure GP9 and using TMSCl as promoter: starting 
from commercially available 6-bromo-1H indole (43.1 mg, 0.200 
mmol), after 3 hours 6'-bromo-1H,1'H-2,3'-biindole 15a (32.0 mg, 
0.103 mmol, 51% yield). was obtained as a brown resin. Rf: 0.41 
(Pentane:EtOAc 7:3). 1H NMR (400 MHz, CD3CN) δ 9.64 (s, 1H, NH), 9.54 (s, 1H, NH), 7.91 
(dd, J = 8.5, 0.6 Hz, 1H, ArH), 7.70 (dd, J = 1.8, 0.6 Hz, 1H, ArH), 7.65 (d, J = 2.7 Hz, 1H, 
ArH), 7.59 – 7.52 (m, 1H, ArH), 7.41 (dd, J = 8.0, 1.0 Hz, 1H, ArH), 7.31 (dd, J = 8.5, 1.8 Hz, 
1H, ArH), 7.11 (ddd, J = 8.1, 7.1, 1.3 Hz, 1H, ArH), 7.04 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H, ArH), 
6.76 (dd, J = 2.2, 0.9 Hz, 1H, ArH). 13C NMR (101 MHz, CD3CN) δ 138.6, 137.3, 134.1, 130.4, 
125.0, 124.4, 124.1, 122.2, 122.1, 120.5, 120.4, 116.2, 115.6, 111.5, 110.3, 99.1. IR ν 3413 (w), 
3395 (w), 1615 (m), 1595 (m), 1454 (s), 1308 (s), 1230 (m), 1103 (m), 894 (s). HR-ESI-MS: 
calcd for C16H12Br
79N2
+ 311.0178 [M + H]+; found 311.0173. 
 
6'-Fluoro-1H,1'H-2,3'-biindole (15b) 
 Following procedure GP9 and using TMSCl as promoter: starting 
from commercially available 6-fluoro-1H indole (30.0 mg, 0.200 
mmol), after 3 hours 6'-fluoro-1H,1'H-2,3'-biindole 15b (28.0 mg, 
0.112 mmol, 56% yield) was obtained as a brown oil. Rf: 0.42 
(Pentane:EtOAc 7:3). 1H NMR (400 MHz, Acetone-d6) δ 10.63 (s, 1H, NH), 10.43 (s, 1H, NH), 
8.04 (dd, J = 8.8, 5.3 Hz, 1H, ArH), 7.85 (d, J = 2.5 Hz, 1H, ArH), 7.55 (dd, J = 7.5, 1.3 Hz, 
1H, ArH), 7.37 (dd, J = 7.9, 1.3 Hz, 1H, ArH), 7.25 (dd, J = 9.8, 2.4 Hz, 1H, ArH), 7.13 – 6.93 
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(m, 3H, ArH), 6.86 – 6.71 (m, 1H, ArH) (13C could not recorded due to unstable nature of this 
compound in solution).  HR-ESI-MS calcd for C16H11FN2
+ 250.0901 [M]+ found 250.0903. 
 
6-Bromo-5',6'-dimethoxy-1H,1'H-2,3'-biindole (15c) 
Following procedure GP9: using commercially available 5,6-
dimethoxy-1H-indole (53.2 mg, 0.200 mmol), after 3 hours 6-
bromo-5',6'-dimethoxy-1H,1'H-2,3'-biindole 15c (38.1 mg, 
0.103 mmol, 34% yield) was obtained as a yellow oil. Rf: 0.35 
(Pentane:EtOAc 1:1). 1H NMR (400 MHz, CDCl3) δ 8.21 (br 
s, 1H, NH), 8.16 (br s, 1H, NH), 7.53 (s, 1H, ArH), 7.49 (d, J = 8.4 Hz, 1H, ArH), 7.35 (s, 1H, 
ArH), 7.32 (d, J = 2.6 Hz, 1H, ArH), 7.22 (dd, J = 8.3, 1.7 Hz, 1H, ArH), 6.94 (s, 1H, ArH), 
6.70 (dd, J = 2.0, 0.9 Hz, 1H, ArH), 3.99 (s, 3H, OMe), 3.94 (s, 3H, OMe). 13C NMR (101 
MHz, CDCl3) δ 147.8, 146.0, 136.8, 134.2, 130.8, 128.5, 123.2, 121.0, 119.8, 118.1, 114.6, 
113.3, 109.8, 101.4, 99.0, 94.6, 56.5, 56.2 (the compound spontaneously decompose in acidic 
deuterated solvents, it presents about 9% of decomposed products – grease signal not purified). 
IR ν 2873 (m), 1691 (m), 1349 (m), 1277 (w), 1046 (s), 970 (m), 850 (s), 766 (w), 749 (w). 
HR-ESI-MS calcd for C18H15
79BrN2NaO2
+ [M+Na]+ 393.0209; found 393.0201. 
 
2-(3-Methoxythiophen-2-yl)-1H-indole (16) 
 Following procedure GP9: using commercially available 3-
methoxythiophen (22.8 mg, 0.200 mmol), after 3 hours 2-(3-
methoxythiophen-2-yl)-1H-indole 16 (13.0 mg, 60.0 µmol, 28% yield) 
was obtained as a green oil. Rf: 0.6 (Pentane:EtOAc 9:1). 1H NMR (400 MHz, CDCl3) δ 9.30 
(s, 1H, NH), 7.56 (dq, J = 7.7, 1.0 Hz, 1H, ArH), 7.38 (dt, J = 8.0, 1.0 Hz, 1H, ArH), 7.19 – 
7.04 (m, 3H, ArH), 6.90 (d, J = 5.5 Hz, 1H, ArH), 6.60 (dd, J = 2.1, 0.9 Hz, 1H, ArH), 4.04 (s, 
3H, OCH3). 13C NMR (101 MHz, CDCl3) δ 153.5, 135.8, 131.8, 128.3, 122.3, 121.6, 119.9, 
119.9, 116.3, 112.8, 110.5, 97.9, 58.9. IR ν 3440 (w), 1706 (w), 1588 (w), 1516 (w), 1457 (w), 
1380 (m), 1293 (m), 1069 (s), 776 (s), 747 (s). HR-ESI-MS: calcd for C13H12NOS
+ 
230.0634[M + H]+; found 230.0637. 
  
S62 
 
4. Working model for the reaction mechanism. 
In order to establish the role of both promoter and fluorinated solvent we performed several 
NMR experiments in deuterated CDCl3 (solvent of characterization) and CD2Cl2 (solvent of 
reaction).We screened different equivalents of HFIP and TMSCl.  As we’ve seen in the control 
experiment, the presence of TMSCl as promoter is essential. When we added 1.0 equiv. of 
TMSCl to reagent 2a in deuterated solvent, we immediately observed decomposition of the 
reagent in its constituents. The observed aromatic peaks corresponds to the ones of iodo-benzoic 
acid.[26] In the carbon it is possible to observe that the hypervalent character of C-I bond is lost, 
as it shift from 78 ppm to 94 ppm. HFIP alone doesn’t promote immediate decomposition but 
shift of peaks; it is possible that it coordinates with the reagent via hydrogen bond-type 
interactions. However, HFIP plays an important role in stabilizing the intermediate form, as the 
sole Lewis Acid would immediately decompose the hypervalent iodine reagent. When we 
mixed both fluorinated solvent and TMSCl we observed decomposition in absence of a suitable 
nucleophile. 
 
 
IndoleBX 2a in CDCl3 0.1 M 
IndoleBX 2a in CDCl3 0.1 M 
+ 1.0 equiv. TMSCl 
IndoleBX 2a in CDCl3 0.1 M 
+ 0.50 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 1.0 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 3.0 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 10 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 10 equiv. HFIP – 1.0 equiv. 
TMSCl 
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NMR analysis in CD2Cl2 showed the same reactivity pattern as in CDCl3  
 
 
 
IndoleBX 2a in CDCl3 0.1 M 
IndoleBX 2a in CDCl3 0.1 M 
+ 1.0 equiv. TMSCl 
IndoleBX 2a in CDCl3 0.1 M 
+ 0.50 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 1.0 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 3.0 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 10 equiv. HFIP 
IndoleBX 2a in CDCl3 0.1 M 
+ 10 equiv. HFIP – 1.0 equiv. 
TMSCl 
IndoleBX 2a in CD2Cl2 0.1 
M + 1.0 equiv. TMSCl 
IndoleBX 2a in CD2Cl2 0.1 
M + 0.50 equiv. HFIP 
IndoleBX 2a in CD2Cl2 0.1 
M + 1.0 equiv. HFIP 
IndoleBX 2a in CD2Cl2 0.1 
M + 3.0 equiv. HFIP 
IndoleBX 2a in CD2Cl2 0.1 M 
+ 10 equiv. HFIP – 1.0 equiv. 
TMSCl 
IndoleBX 2a in CD2Cl2 0.1 
M + 10 equiv. HFIP 
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We currently hypothetize three possible mechanisms for this transformation, a Path A would 
involve ligand exchange with the nucleophile and reductive elimination to afford the product. 
Path B envisages a SET pathway and Path C a SNAr pathway, in which a iodonium carbene 
resonance structure may play a role (Scheme S1). 
Scheme S1: Three mechanistical hypotheses for the hypervalent iodine-mediated oxidative coupling. 
 
IndoleBX 2a in CD2Cl2 0.1 
M + 1.0 equiv. TMSCl 
IndoleBX 2a in CD2Cl2 0.1 
M + 0.50 equiv. HFIP 
IndoleBX 2a in CD2Cl2 0.1 
M + 1.0 equiv. HFIP 
IndoleBX 2a in CD2Cl2 0.1 
M + 3.0 equiv. HFIP 
IndoleBX 2a in CD2Cl2 0.1 M 
+ 10 equiv. HFIP – 1.0 equiv. 
TMSCl 
IndoleBX 2a in CD2Cl2 0.1 
M + 10 equiv. HFIP 
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As already reported,[27] heteroatom-ligands of the I(III) can exchange with different nucleophiles. 
For Path A, two pathways could be considered: associative and dissociative (Scheme S2). In the 
associative pathway we speculate that the Cl- derived from TMSCl rapidly add to the  C-I σ* 
orbital and form a trans tetracoordinated [12-I-4] iodate I with a square-planar arrangement. 
Rapid isomerization and elimination of the carboxylate form a λ3 -iodane III. The addition-
elimination sequence proceed at a low-energy barrier and is generally reversible. Conversely, 
the dissociative pathway would involve a high-energy dicoordinated [8-I-2] iodonium species, 
possibly stabilized by ionic or hydrogen interaction with the protic fluorinated solvent on apical 
sites to arrive at II. Addition of Cl- would lead to intermediate III. For addition of (hetero)aryl-
H the same mechanisms are considered, but a rearomatization of the nucleophile has also to be 
accounted to get intermediate IV. 
 
Scheme S2:  Associative and Dissociative pathways for the formation of III and IV. 
To explain the regio-distribution of the product, we hypothetize that IV, the C3 regiosisomer 
would exist in equilibrium with V, the C2 one (Scheme S3). When a C3-alkylated indole is used 
as nucleophile, the equilibrium should be shifted towards intermediate IV due to sterical 
hindrance. 
S66 
 
 
Scheme S3: Equilibrium of two regioisomers IV and V. 
Finally, the hypervalent λ3 -iodanes IV or V would undergo reductive elimination to afford the 
coupled product and iodo-benzoic acid as monovalent iodide. The process if facile because the 
hypervalent iodine is a hypernucleofuge (hypervalent leaving group better than a super-ion as -
OTf). The process is most probably concerted, (as shown in Scheme S4) and require therefore 
isomerization of the reagent to have the two desired aryl groups in cis relationship. In this step, 
elimination to form the more sterically hindered product may be more difficult, allowing also 
to rationalize the regioselectivity based on kinetics instead of thermodynamics. A stepwise, 
mechanism involving high energy carbo-cation and –anion intermediates is less probable. A 
weak point of pathway A is that it is difficult to rationalize the high selectivity observed for bi-
heteroaryl formation: In fact, at least some reductive elimination to give undesired cross-
products with iodobenzoic acid would have been expected. 
 
Scheme S4: Reductive elimination  
Another proposal involves, as theorized by Kita for the oxidative coupling of arenes and 
heterocycles,[28,29] a radical mechanism. This would be a viable alternative to the ligand 
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exchange proposed in Path A. The TMSCl should induce the formation of Charge-Transfer 
complex VI (CT-complex) between the (hetero)arene and the electrophilic hypervalent iodine 
(Scheme S5). A SET would form the oxidized cationic radical (hetero)arene and transfer one 
electron on the electrophilic iodane. The aromatic cation radical intermediate VII could be 
stabilized by the enamine bond of the indole, with the iodane shifting between the C2-C3 
carbons. Intramolecular deprotonation by either the chlorine moiety or the carboxylate the 
would afford intermediates VIII and IX. Final SET recombination would afford the 
corresponding mixed bi-(hetero)arenes. Alternatively, recombination on iodine would lead 
back to intermediate IV and V, which could then undergo reductive elimination. 
 
Scheme S5: SET pathway 
Finally, Path C takes into account the donating effect of the N-lone pair in stabilizing III via 
its resonance form X. SNAr attack of the nucleophile would form intermediate XI. Finally, 1,2-
proton shift of the C2-proton on the C3-iodo-carbene would afford the desired product (Scheme 
S6). 
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Scheme S6: Vicarious nucleophilic aromatic substitution. 
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5. Further Modifications of the (Hetero)-Arylated Indoles. 
 
All commercially available chemicals were purchased from the suppliers quoted in Paragraph 
1.0 of Supplementary Informations: these chemicals were purified through a short plug of celite 
prior to their use in catalysis.  
Synthesis of  2-bromo-12-methyl-5,12-dihydroindolo[3,2-a]carbazole (18) 
 
Following a reported procedure,[30] in a flame dried vial under nitrogen atmosphere, 5'-bromo-
1-methyl-1H,1'H-2,3'-biindole 8j (32.5 mg, 1.00 mmol, 1.00 equiv.) was dissolved in AcOH (1 
mL, 0.1 M); commercially available 2,2-diethoxy-N,N-dimethylethanamine (20.0 µL, 1.00 
mmol, 1.00 equiv.) 17 was added under vigorous stirring. The reaction mixture was heated up 
to reflux (135 °C) and monitored via TLC (1:1 Pentane/EtOAc). Upon complete consumption 
of the starting material (1 hour), the reaction was cooled to room temperature and the solvent 
removed under reduced pressure. The crude product was purified via flash chromatography 
(gradient 5:1-1:2 Pentane:EtOAc) to afford 2-bromo-12-methyl-5,12-dihydroindolo[3,2-
a]carbazole 18 (28.3 mg, 81.0 µmol, 81% yield) as a yellow oil. Rf 0.4 (Pentane:EtOAc 1:1) 
1H NMR (400 MHz, CDCl3) δ 8.64 (d, J = 1.7 Hz, 1H, ArH), 8.37 (s, 1H, NH), 8.13 (d, J = 8.4 
Hz, 1H, ArH), 8.09 (dt, J = 7.7, 0.9 Hz, 1H, ArH), 7.54 – 7.43 (m, 3H, ArH), 7.37 (d, J = 8.5 
Hz, 1H, ArH), 7.33 – 7.26 (m, 2H, ArH), 4.48 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) δ 
140.8, 140.4, 137.5, 137.2, 127.1, 125.2, 124.1, 124.1, 123.5, 119.7, 119.6, 118.9, 116.6, 112.3, 
112.1, 108.9, 107.0, 103.5, 34.7. IR ν 3053 (w), 2939 (w), 1619 (w), 1589 (w), 1466 (s), 1369 
(m), 1339 (m), 1272 (m), 1244 (m), 1145 (m), 1092 (w), 830 (m), 790 (s), 748 (a). No high 
resolution mass spectrum could be obtained for this compound due to insufficient ionization. 
 
Synthesis of 2-chloro-5,12-dimethyl-6,7-diphenyl-5,12-dihydroindolo[3,2-a]carbazole (20) 
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Following a reported procedure,[31] Pd(OAc)2 (2.25 mg, 10.0 µmol, 10.0 mol%), K2CO3 (4.15 
mg, 30.0 µmol, 30 mol%), TBAB (16.0 mg, 50.0 µmol, 0.5 equiv.), PivOH (10.2 mg, 0.100 
mmol, 1.00 equiv.), 5'-chloro-1,1'-dimethyl-1H,1'H-2,3'-biindole 8d (29.5 mg, 0.100 mmol) 
and commercially available diphenylacetylene 19 (35.6 mg, 0.200 mmol, 2.00 equiv.) were 
added to a flame dried vial under nitrogen atmosphere. The tube was purged with O2 three times 
before DMF (1.0 mL, 0.1 M) was added. The reaction mixture was stirred at 100 °C under O2 
(1 atm) for 12 h and was monitored by TLC (Pentane:EtOAc 4:1). The solution was then cooled 
to RT, diluted with ethyl acetate (10 mL), washed with H2O (3x10 mL), dried over MgSO4, 
filtered, and dried under vaccum. The crude product was purified by column chromatography 
on silica gel (gradient 10:1 to 4:1 Pentane:EtOAc) to afford 2-chloro-5,12-dimethyl-6,7-
diphenyl-5,12-dihydroindolo[3,2-a]carbazole 20 (35.1 mg, 75.0 µmol, 75% yield). Rf 0.7 
(Pentane:EtOAc 4:1) 1H NMR (400 MHz, CDCl3) δ 8.58 (d, J = 1.9 Hz, 1H, ArH), 7.49 (d, J 
= 8.1 Hz, 1H, ArH), 7.43 (dd, J = 8.7, 2.0 Hz, 1H, ArH), 7.37 (d, J = 7.5 Hz, 1H, ArH), 7.35 – 
7.17 (m, 11H, ArH), 6.92 (t, J = 7.5 Hz, 1H, ArH), 6.51 (d, J = 7.9 Hz, 1H, ArH), 4.50 (s, 3H, 
NMe), 3.26 (s, 3H, NMe). 13C NMR (101 MHz, CDCl3) δ  142.2, 140.1, 139.8, 139.7, 138.4, 
136.7, 136.5, 132.2, 130.2, 127.9, 127.3, 126.7, 124.5, 124.3, 124.3, 124.0, 122.1, 121.9, 121.1, 
119.5, 118.3, 115.2, 110.0, 108.9, 106.5, 35.5, 33.1 (one aromatic Carbon not resolved). IR ν 
2975 (w), 2943 (w), 2903 (w), 1722 (w), 1613 (w), 1468 (s), 1422 (m), 1369 (m), 1338 (m), 
1271 (m), 1247 (m), 1208 (w), 1087 (m), 1045 (m), 880 (w), 787 (m), 750 (s). HR-ESI-MS 
calcd for C32H24ClN2
+ [M+H]+ 471.1623; found 471.1616. 
 
Synthesis of 3-Chloro-2-(2,4,6-trimethoxyphenyl)quinolone (21) 
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With slight modification of a reported procedure[32,33] 50% aqueous KOH (72.0 L, 0.635 
mmol, 7.50 equiv.) was added to a vigorously stirred solution of 2-(2,4,6-trimethoxyphenyl)-
1H-indole 14a (24.0 mg, 85.0 µmol, 1.00 equiv.) and nBu4NHSO4 (2.88 mg, 8.47 μmol, 0.100 
equiv.) in chloroform (1.10 mL) under ice-cooling bath. The reaction mixture was stirred at 0 
°C for 2 h and left overnight at room temperature. After 16 h The aqueous layer was separated 
and extracted with chloroform. The organic layers were dried over MgSO4. After filtration and 
evaporation, the crude was purified by PTLC,and 3-chloro-2-(2,4,6-
trimethoxyphenyl)quinoline 21 (20.0 mg, 60.0 µmol, 72% yield) was obtained as brown 
crystalline solid. M.p. 158-162 °C Rf: 0.35 (25% EtOAc in Pentane). 1H NMR (400 MHz, 
Acetone-d6) δ 8.44 (s, 1H, ArH), 8.09 – 8.02 (m, 1H, ArH), 7.97 (dd, J = 8.1, 1.5 Hz, 1H, ArH), 
7.81 – 7.73 (m, 1H, ArH), 7.65 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H, ArH), 6.37 (s, 2H, ArH), 3.90 (s, 
3H, p-OCH3), 3.70 (s, 6H, o-OCH3). 13C NMR (101 MHz, Acetone-d6) δ 163.1, 159.8, 154.8, 
147.1, 135.4, 131.2, 130.3, 129.8, 128.9, 128.1, 127.8, 110.5, 91.5, 56.1, 55.7. IR ν 2256 (w), 
1728 (m), 1704 (s), 1611 (w), 1340 (w), 1249 (s), 1158 (w), 1131 (w), 1035 (w), 971 (w). HR-
ESI-MS: calcd for C18H17ClNO3
+ 330.0891[M + H]+; found 330.0895. 
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6. Crystal Structures. 
 
 
A single crystal was grown by slow diffusion of the solution of 13h in CDCl3. Supplementary 
crystallographic data for this compound have been deposited at Cambridge Crystallographic 
Data Centre (1824408) and can be obtained free of charge via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
A single crystal was grown by removal of reaction solvent from 14a by evaporation. 
Supplementary crystallographic data for this compound have been deposited at Cambridge 
Crystallographic Data Centre (1824407) and can be obtained free of charge via 
www.ccdc.cam.ac.uk/data_request/cif. 
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7. Determination of the regio-distribution. 
 
Given the all-aromatic nature of the mixed bi-indole frameworks, NMR studies were required 
to assign the correct regiodistribution of the products. NMR-analysis of bis-methylated bi-
indoles 8a-8h already shown a 3’-2/2’-3 connectivity between the two heterocyclic core. We 
then decide to procede in steps, focusing our attention on mixed bi-indole obtained when a NH-
indole was used as nucleophile in the reaction. 
In Figure 7.1 all four possible regioisomers I-IV are reported: in order to determine the correct 
structure we performed bidimensional NMR analysis of product 8i-8j and their derivatives 35-
36. We concentrated our attention to the 
H-signal at about 6.6 ppm: given the shift 
we postulated its belonging to either C2-
C3 carbons of one of the two indoles. 
HMBC analysis of products 8i-8j  didn’t 
show correlation between the NCH3-
carbon and the H-signal at about 6.6 ppm. 
For this reason we were able to exclude 
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regioisomers of classes I and II and assign the singlet to a C3-carbon.  
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To distinguish between the remaining two regioisomers III and IV, it was not possible to use 
COSY correlation between the NH bond and the C2-H, as the signal was too weak, 
independently of the substitution pattern. We therefore methylated 8i-8j to obtain 35-36.  
Following general procedure GP6: the corresponding biindoles 8i-8j (0.100 mmol, 1.00 equiv.) 
were dissolved in dry THF (1.00 mL, 0.1 M). Sodium hydride (4.00 mg, 1.00 mmol, 1.00 equiv. 
60% suspension in mineral oil) was slowly added under N2 flow at 0 °C. After being stirred at 
0 °C for 15 min,the reaction mixture was allowed to warm to r.t for 1.5 h. It was then cooled 
back to 0 °C and methyl iodide (11.0 µL, 1.00 mmol, 1.00 equiv.) was added. The mixture was 
warmed to r.t. and stirred overnight. After cooling again to 0 °C, the reaction was quenched 
with water (10 mL), extracted with Et2O (3 x 10 mL), the combined organic layers were dried 
over MgSO4, and the solvent removed under reduced pressure. The resulting crude product was 
purified via flash column chromatography (Pentane:EtOAc 4:1) to give methylated bi-indoles 
35-36. 
 
5'-Fluoro-1,1'-dimethyl-1H,1'H-2,3'-biindole (35). 
Following general procedure GP6 on a 0.1 mmol scale and using 1.0 
equiv. of NaH and MeI: starting from 5'-fluoro-1-methyl-1H,1'H-2,3'-
biindole 8i (26.4 mg, 0.100 mmol, 1.00 equiv.), 5'-fluoro-1,1'-
dimethyl-1H,1'H-2,3'-biindole xx (21.3 mg, 77.0 µmol, 77% yield) as 
a yellow oil. Rf 0.4 (Pentane:EtOAc 4:1) 1H NMR (400 MHz, CDCl3) 
δ 7.65 (d, J = 7.7 Hz, 1H, ArH), 7.36 (ddd, J = 11.9, 8.9, 1.7 Hz, 2H, ArH), 7.31 (dd, J = 8.9, 
4.2 Hz, 1H, ArH), 7.26 – 7.22 (m, 2H, ArH), 7.15 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, ArH), 7.06 
(td, J = 9.0, 2.5 Hz, 1H, ArH), 6.60 (d, J = 0.9 Hz, 1H, ArH), 3.89 (s, 3H, NMe), 3.75 (s, 3H, 
NMe). 13C NMR (101 MHz, CDCl3) δ 158.5 (d, J = 235.7 Hz), 137.9, 134.4, 133.6, 129.8, 
128.3, 128.0 (d, J = 10.1 Hz), 121.1, 120.0, 119.6, 110.8 (d, J = 26.6 Hz), 110.2 (d, J = 9.8 Hz), 
109.3, 107.3 (d, J = 4.6 Hz), 105.2 (d, J = 24.2 Hz), 101.4, 33.3, 30.9.  IR ν 3054 (w), 2929 
(w), 2854 (w), 1626 (w), 1592 (w), 1489 (m), 1467 (w), 1280 (m), 1241 (w), 1194 (w), 1119 
(w), 1013 (w), 913 (m), 748 (s). HR-ESI-MS calcd for C18H16FN2
+ [M+H]+ 279.1292; found 
279.1287. 
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5'-Bromo-1,1'-dimethyl-1H,1'H-2,3'-biindole (36). 
Following general procedure GP6 on a 0.1 mmol scale and using 1.0 
equiv. of NaH and MeI: starting from 5'-bromo-1-methyl-1H,1'H-
2,3'-biindole 8j (32.5 mg, 0.100 mmol, 1.00 equiv.) 5'-bromo-1,1'-
dimethyl-1H,1'H-2,3'-biindole 36 (27.9 mg, 82.0 µmol, 82% yield) 
was obtained as yellow oil. Rf 0.75 (Pentane:EtOAc 4:1) 1H NMR (400 MHz, CDCl3) δ 7.81 
(dd, J = 1.9, 0.5 Hz, 1H, ArH), 7.64 (m, 1H, ArH), 7.38 (dd, J = 4.1, 1.4 Hz, 1H, ArH), 7.36 
(dd, J = 3.6, 1.4 Hz, 1H, ArH), 7.25 – 7.21 (m, 2H, ArH), 7.17 (s, 1H, ArH), 7.14 (ddd, J = 8.0, 
7.1, 1.1 Hz, 1H, ArH), 6.59 (s, 1H, ArH), 3.85 (s, 3H, NMe), 3.72 (s, 3H, NMe). 13C NMR (101 
MHz, CDCl3) δ 137.9, 135.6, 134.0, 129.3, 129.3, 128.2, 125.2, 122.8, 121.2, 120.1, 119.7, 
113.7, 111.0, 109.4, 107.0, 101.7, 33.2, 30.9. IR ν 2957 (w), 2932 (w), 2869 (w), 1718 (s), 1610 
(w), 1537 (w), 1452 (w), 1436 (w), 1385 (m), 1255 (m), 1214 (m), 1162 (m), 1060 (w), 1035 
(w), 880 (w), 803 (w), 721 (m). HR-ESI-MS calcd for C18H16
79BrN2
+ [M+H]+ 339.0491; found 
339.0485.  
 
 
The HMBC analysis showed interaction 
between the H-singlet at 7.25 (35) and 
7.16 (36) and the newly installed NCH3, 
thereby excluding the 2’-2 connection and 
allowing to assign the structure. As 
expected we obtained the 3’-2 connection. 
The structure of the other bi-indoles 
obtained in the scope was assigned by 
analogy, except for compounds 8l-8m. 
The latter compounds were obtained with a C3-alkylated indole as nucleophile and the steric 
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hindrance played an important role in reversing the regio-distribution. An insight on the 
mechanism is given in SI-Par.4. 
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6. DSC studies. 
 
DSC analysis of C2-NBoc-IndoleDBX (13a) 
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8. Spectra of new compounds 
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Potassium trifluoro(1-(tert-butoxycarbonyl)-6-methoxy-1H-indol-2-yl)borate (11c) 
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Potassium trifluoro(1-(tert-butoxycarbonyl)-6-bromo-1H-indol-2-yl)borate (11d): 
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Potassium trifluoro(1-(tert-butoxycarbonyl)-3-methyl-1H-indol-2-yl)borate (11e): 
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Potassium trifluoro(1-(tosyl)-1H-indol-2-yl)borate (11f): 
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Potassium trifluoro(2-(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione)borate (11g): 
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1-(Tert-butyl 1H-indole-1-carboxylate)-1H-1λ3 -benzo[b]iodo-3(2H)-one (13a):  
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1-(2-1-(Tosyl)-1H-indol-2-yl)-1H-1λ3 -benzo[b]iodo-3(2H)-one (13b):  
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1-(2-Tert-butyl 1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo[d][1,2]iodoxol  (13c):  
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1-(2-1-Tosyl-1H-indole)-3,3-dimethyl-1,3-dihydro-1λ3-benzo[d][1,2] iodoxole (13d):  
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1-(2-5-Methoxy-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo [d][1,2]iodoxole (13e):  
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1-(2-6-Methoxy-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo [d][1,2]iodoxole (13f):  
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1-(2-5-Bromo-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-benzo 
[d][1,2]iodoxole (13g):  
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1-(2-3-Methyl-1-tert-butyl-1H-indole-1-carboxylate)-3,3-dimethyl-1,3-dihydro-1λ3-benzo 
[d][1,2]iodoxole (13h):  
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1-(2-(1H-Indol-3-yl)ethyl)isoindoline-1,3-dione)-3,3-dimethyl-1,3-dihydro-1λ3-
benzo[d][1,2] iodoxole (13i):  
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1-Methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole (7a) 
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1-Methyl-2,3-bis(2,4,6-trimethoxyphenyl)-1H-indole (8). 
  
S99 
 
 
 
 
 
S100 
 
5-Iodo-1-methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole (7b) and and 5-iodo-1-methyl-
2,3-bis(2,4,6-trimethoxyphenyl)-1H-indole (7b’) 
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1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,4,6-trimethoxyphenyl)-1H-
indole (7c)
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S104 
 
1,2-Dimethyl-3-(2,4,6-trimethoxyphenyl)-1H-indole (7d) 
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1,1'-Dimethyl-1H,1'H-2,3'-biindole (8b) 
 
 
5'-Methoxy-1,1'-dimethyl-1H,1'H-2,3'-biindole (8c) and 5'-methoxy-1,1'-dimethyl-
1H,1'H-2,7'-biindole (8c’) 
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5'-Chloro-1,1'-dimethyl-1H,1'H-2,3'-biindole (8d) 
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5'-Iodo-1,1'-dimethyl-1H,1'H-2,3'-biindole (8e) 
 
 
 
S110 
 
1,1'-Dimethyl-5'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-biindole (8f) 
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1,1'-Dimethyl-1H,1'H-[2,3'-biindol]-6'-ol (8g) 
 
 
1-Methyl-1H,1'H-2,3'-biindole (8h) 
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5'-Fluoro-1-methyl-1H,1'H-2,3'-biindole (8i) 
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5'-Bromo-1-methyl-1H,1'H-2,3'-biindole (8j) 
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1,1',3-Trimethyl-1H,1'H-2,3'-biindole (8k) 
 
 
 
 
S116 
 
2-(1'-Methyl-1H,1'H-[2,3'-biindol]-3-yl)ethanol (8l) 
  
 
 
S117 
 
 
5-Iodo-1,1'-dimethyl-1H,1'H-2,3'-biindole (8m) 
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5'-Methoxy-1,1'-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-
biindole (8n).
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5'-Nitro-1,1'-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H,1'H-2,3'-
biindole (8o) 
 
 
1-Methyl-2-(1-methyl-1H-pyrrol-2-yl)-1H-indole (9a) 
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1-Methyl-2-(1-phenyl-1H-pyrrol-2-yl)-1H-indole (9b) 
 
 
1-methyl-2-(1-phenyl-1H-pyrrol-3-yl)-1H-indole (9b’) 
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2-(3-Methoxythiophen-2-yl)-1-methyl-1H-indole (10a) 
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2-(2,5-Dimethylthiophen-3-yl)-1-methyl-1H-indole (10b) 
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2-(2,4,6-Trimethoxyphenyl)-1H-indole (14a)  
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5-Methoxy-2-(2,4,6-trimethoxyphenyl)-1H-indole (14b) 
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6-Methoxy-2-(2,4,6-trimethoxyphenyl)-1H-indole (14c) 
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6-Bromo-2-(2,4,6-trimethoxyphenyl)-1H-indole (14d) 
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3-Methyl-2-(2,4,6-trimethoxyphenyl)-1H-indole (14e)  
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2-(2-(2-(2,4,6-Trimethoxyphenyl)-1H-indol-3-yl)ethyl)isoindoline-1,3-dione (14f) 
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2-(2,4,6-Trimethoxy-3-methylphenyl)-1H-indole (14g)  
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3-Methyl-2-(2,4,6-trimethoxy-3-methylphenyl)-1H-indole (14h)  
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6'-Bromo-1H,1'H-2,3'-biindole (15a)  
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6'-Fluoro-1H,1'H-2,3'-biindole (15b) 
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6-Bromo-5',6'-dimethoxy-1H,1'H-2,3'-biindole (15c) 
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2-(3-Methoxythiophen-2-yl)-1H-indole (16)  
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2-Bromo-12-methyl-5,12-dihydroindolo[3,2-a]carbazole (18)
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2-Chloro-5,12-dimethyl-6,7-diphenyl-5,12-dihydroindolo[3,2-a]carbazole (20) 
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3-Chloro-2-(2,4,6-trimethoxyphenyl)quinolone (21) 
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5'-Fluoro-1,1'-dimethyl-1H,1'H-2,3'-biindole (35)
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5'-Bromo-1,1'-dimethyl-1H,1'H-2,3'-biindole (36) 
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